data_2rt4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rt4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.943 0.401 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -144.33 134.49 24.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.01 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.07 -178.55 3.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.464 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.4 p-90 -169.48 -152.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.318 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.9 m -90.95 26.57 2.07 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.22 35.2 4.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 73.4 t80 -97.13 123.16 40.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.728 0.299 . . . . 0.0 110.764 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.94 108.01 40.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.996 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -70.36 -34.29 12.85 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.419 2.079 . . . . 0.0 111.724 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -53.66 -29.84 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 p -127.27 14.05 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.674 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.63 27.81 3.27 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -133.3 164.58 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.429 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 95.8 m95 -81.57 -179.14 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -72.8 -82.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.359 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -170.25 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 111.228 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.0 p -52.0 -40.26 60.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.172 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 1.8 mp -101.95 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 105.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -66.81 157.87 31.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.022 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.78 1.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.605 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.54 -84.79 0.99 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.547 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.925 0.393 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -141.7 109.38 5.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -100.06 171.18 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.004 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.457 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.2 p-90 -170.11 -155.92 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -93.99 27.61 2.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -76.47 -27.94 60.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.563 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -49.49 118.65 2.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.867 0.365 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -102.71 95.06 5.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.56 -21.54 62.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.216 1.944 . . . . 0.0 112.073 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -67.88 -32.04 72.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.0 p -115.99 12.9 15.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.08 31.43 2.09 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.311 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -153.33 148.25 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -70.55 151.34 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.82 -43.54 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.226 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.0 p -65.25 177.59 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.072 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -70.07 -11.59 60.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.269 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.4 mm -57.92 158.73 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.08 122.98 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.126 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -91.64 161.49 14.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.79 -55.93 5.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.76 -115.75 3.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.532 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.276 -1.291 . . . . 0.0 112.482 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 20' ' ' ILE . 35.3 m . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.577 0.227 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -74.33 147.03 42.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.021 0.439 . . . . 0.0 111.527 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HG3' ' CH2' ' A' ' 16' ' ' TRP . 29.9 tt0 -100.12 160.57 14.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -167.47 -161.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.65 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -56.55 -18.54 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.37 -28.41 2.2 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.073 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -80.36 117.39 21.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -108.08 92.48 9.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 15.3 Cg_endo -58.35 -19.94 45.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.319 2.013 . . . . 0.0 112.128 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -69.97 -43.51 71.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 p -102.4 13.45 34.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.14 28.0 4.0 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.023 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -148.23 154.35 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.942 0.401 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.458 ' CG ' ' HA ' ' A' ' 22' ' ' TYR . 16.6 m95 -83.17 -176.86 6.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.96 -79.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 t -170.28 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.237 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.7 t -50.48 -37.95 41.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.314 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG22 ' CG2' ' A' ' 3' ' ' VAL . 41.5 mm -119.15 157.88 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.26 133.4 19.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.31 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HA ' ' CG ' ' A' ' 16' ' ' TRP . 43.4 p90 -105.06 163.2 12.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.09 6.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.603 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.61 -93.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.465 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 120.964 0.412 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -170.36 114.91 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.043 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -99.97 161.89 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.43 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.2 p-90 -152.73 -152.14 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -94.48 33.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.669 0.271 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -90.58 -30.23 12.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.668 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -54.54 116.02 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.93 107.18 48.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.56 -36.15 20.59 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.463 2.108 . . . . 0.0 111.58 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -54.0 -30.41 47.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.246 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.8 p -119.97 9.9 11.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.786 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.06 29.62 1.58 Allowed Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.247 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.3 p -144.47 152.03 40.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.908 0.385 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 30.1 m95 -81.24 174.73 11.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -131.54 -43.35 1.02 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.425 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 t -65.61 -171.11 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.031 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.3 m -69.54 -12.59 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.231 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG23 ' CZ3' ' A' ' 16' ' ' TRP . 43.8 mm -61.88 152.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.736 0.303 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.26 122.85 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.47 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.8 p90 -91.46 162.64 14.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.213 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 -29.25 12.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.93 113.43 0.44 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.54 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 20' ' ' ILE . 35.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -85.16 151.98 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.85 177.69 5.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.452 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.6 p-90 -170.02 -158.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.479 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.8 m -94.77 39.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.7 0.286 . . . . 0.0 111.2 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -94.75 -26.45 13.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.659 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 16' ' ' TRP . 89.2 t80 -49.56 119.44 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.46 94.51 4.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.8 -15.58 49.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.331 2.021 . . . . 0.0 112.287 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -62.67 -40.81 98.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.7 p -120.64 13.49 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.498 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 48.33 59.35 6.51 Favored Glycine 0 CA--C 1.517 0.212 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.204 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -157.34 175.43 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.0 m95 -113.76 116.09 28.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -68.92 -45.77 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.591 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.6 p -66.37 169.7 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.151 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -63.64 -17.21 62.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 3' ' ' VAL . 38.4 mm -50.85 155.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.936 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.0 125.74 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.884 0.373 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 32.3 p90 -100.8 161.38 13.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.23 59.27 11.0 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.96 -100.81 0.28 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.49 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.412 ' CG2' HG22 ' A' ' 20' ' ' ILE . 35.1 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -65.09 137.39 57.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.953 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -100.19 169.78 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -170.02 -155.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 m -75.13 0.61 15.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.97 -26.38 8.55 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.853 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 85.2 t80 -76.42 116.6 17.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 m-20 -112.59 100.81 51.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.988 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 19.7 Cg_endo -59.76 -24.03 74.17 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.291 1.994 . . . . 0.0 112.135 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -59.53 -31.05 69.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -122.31 12.28 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.5 28.13 4.69 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.034 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -150.12 143.08 24.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 69.4 m95 -63.69 177.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.1 mmm180 -81.27 -83.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.414 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.2 p -170.11 -38.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.2 p -47.22 -41.21 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.412 HG22 ' CG2' ' A' ' 3' ' ' VAL . 45.1 mm -118.42 156.33 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.739 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.81 130.6 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 47.5 p90 -94.1 -178.69 4.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.15 41.74 59.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.593 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.85 102.33 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.415 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.531 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.822 0.344 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -82.01 127.29 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.16 158.38 15.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -170.08 -156.37 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.29 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -63.63 -11.69 27.32 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.04 -27.45 3.53 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.194 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.53 117.45 21.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 7.5 m-20 -115.22 102.67 54.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.7 Cg_endo -60.68 -17.21 48.16 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.284 1.989 . . . . 0.0 112.297 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.7 mmp_? -57.03 -31.95 65.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.576 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 p -131.97 13.17 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.42 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.9 35.94 25.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.989 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -147.94 139.94 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 54.1 m95 -60.9 -175.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.604 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -96.64 -83.66 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.311 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -160.05 -43.17 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.6 m -47.97 -37.46 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.155 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.5 mm -120.05 155.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.69 129.24 19.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.1 p90 -105.87 164.8 11.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.46 . . . . 0.0 111.088 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 53.52 2.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.98 -82.03 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.502 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -170.23 108.23 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -100.2 143.77 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' CE3' ' HB2' ' A' ' 7' ' ' SER . 7.7 p-90 -163.53 -153.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.422 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 49.6 m -64.55 -7.09 9.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.26 -28.74 1.47 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.065 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 91.6 t80 -78.35 120.6 23.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.903 0.382 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.12 98.2 41.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 -23.09 76.43 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.248 1.966 . . . . 0.0 112.068 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -60.35 -38.96 85.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -115.33 13.87 16.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.484 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.21 37.9 8.33 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.137 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.7 p -151.49 156.08 39.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.994 0.426 . . . . 0.0 111.197 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 56.0 m95 -84.48 159.34 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -63.68 -78.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.1 p -170.04 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.157 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -50.95 -30.4 14.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.94 147.82 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.664 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.66 95.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.664 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 23.3 p90 -61.75 164.17 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.327 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.67 38.41 7.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.84 -88.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.476 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.838 0.352 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -135.64 138.31 42.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.08 168.62 9.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.42 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.07 -166.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.611 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -90.84 48.45 1.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.076 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -110.45 -28.39 4.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 88.2 t80 -57.48 136.86 56.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -109.19 102.35 48.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.78 -37.57 44.71 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.333 2.022 . . . . 0.0 111.5 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -54.0 -28.88 40.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.265 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.5 p -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.94 48.56 6.28 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.421 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.7 p -156.31 151.8 26.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 63.2 m95 -86.9 164.33 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.1 mmp_? -62.66 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 t -170.19 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.6 t -55.97 -37.2 68.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 2.0 mp -103.76 148.91 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.42 131.65 48.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.6 p90 -95.03 161.88 13.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.007 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.4 48.72 1.8 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.41 33.38 39.47 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.494 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.991 0.424 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -133.94 131.78 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.815 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.37 174.95 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.432 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -170.01 -164.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -89.91 44.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 111.225 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.92 32.56 5.92 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.458 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -99.52 123.62 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -101.96 91.74 2.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.054 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.04 -22.04 73.5 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 112.12 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -62.32 -36.08 81.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.742 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.32 16.76 11.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.509 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.77 46.67 18.87 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.985 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 50.1 p -154.66 157.36 38.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 90.0 m95 -78.46 -177.59 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.98 -83.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.254 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.1 m -169.22 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.1 m -50.38 -36.62 33.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.368 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.6 mm -114.12 156.77 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.75 123.39 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.097 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 42.2 p90 -85.91 162.57 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 72.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.547 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.53 -46.98 1.09 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.591 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.567 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.79 0.328 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -153.02 104.24 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -100.5 162.59 12.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 6.1 p-90 -160.57 -153.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.146 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -95.21 38.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -93.26 -29.38 10.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.793 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -53.6 113.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.92 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.58 109.0 51.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.27 -38.85 25.16 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.842 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -51.49 -47.37 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.074 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p -101.91 9.47 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.862 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.97 30.08 0.96 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.372 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 p -145.48 152.56 39.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.292 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 27.9 m95 -76.81 160.4 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -116.47 -31.63 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.7 p -78.66 -175.58 4.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -67.56 -17.36 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.421 HG22 ' CZ3' ' A' ' 16' ' ' TRP . 24.7 mm -56.89 149.43 3.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.766 0.317 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 120.19 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 111.179 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 40.1 p90 -83.62 165.82 18.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.139 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.13 27.53 62.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.97 151.36 5.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.494 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.699 0.285 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.32 171.68 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.2 171.13 9.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.432 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -169.96 -165.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.577 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -90.04 46.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -114.93 29.82 7.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.593 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -95.69 126.26 40.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.749 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -106.92 103.64 48.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.67 -38.67 30.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.372 2.048 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -53.15 -29.41 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.164 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.5 p -119.97 11.17 11.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.706 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.77 29.12 1.88 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.171 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -147.54 155.57 41.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 84.9 m95 -69.22 -176.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -80.57 -77.28 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -170.12 -40.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.405 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 80.2 p -51.15 -31.71 20.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.33 157.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.02 112.15 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.232 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 46.9 p90 -65.46 152.24 44.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.37 53.38 46.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.43 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.8 113.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.447 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.537 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.423 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.4 m . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.844 0.354 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.02 129.07 38.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.22 176.46 5.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.438 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.7 p-90 -170.01 -154.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -93.6 23.46 4.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.671 0.272 . . . . 0.0 111.43 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -69.71 -33.8 71.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.488 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t80 -58.19 125.38 22.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.432 . . . . 0.0 111.09 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.7 95.0 39.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.02 -13.55 38.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.638 2.226 . . . . 0.0 112.952 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -60.74 -33.89 73.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.606 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 t -138.42 17.87 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.79 67.99 1.58 Allowed Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.971 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 p -154.24 169.14 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.242 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.474 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 16.7 m95 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.58 -66.34 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.349 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.6 t -58.57 -175.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.2 m -81.32 -0.64 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.426 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.423 HG23 ' CG2' ' A' ' 3' ' ' VAL . 39.3 mm -61.55 160.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.511 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -45.7 123.3 4.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 111.159 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 27.5 p90 -103.94 172.91 6.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.281 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 49.26 58.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.559 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 -72.97 0.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.49 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.819 0.342 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -101.52 -177.08 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -98.06 -179.36 4.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.481 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.7 p-90 -167.92 -155.61 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 25.59 3.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.669 0.271 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -77.3 -31.64 50.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.511 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.426 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 90.2 t80 -47.96 116.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.274 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.46 95.77 4.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.058 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.03 -16.6 55.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.233 1.955 . . . . 0.0 112.236 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.36 -36.66 80.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.3 p -122.92 12.26 9.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.271 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.85 51.81 42.88 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.935 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.9 p -157.13 -177.86 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.426 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 77.1 m95 -110.14 156.32 20.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 74.9 mtp180 -60.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.555 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.9 t -170.33 -39.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t -45.81 -33.53 3.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.412 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 mm -125.63 155.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.819 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.92 132.96 32.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.294 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.3 p90 -97.38 179.1 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.82 -55.92 4.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.42 -88.99 0.94 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.467 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.848 0.356 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.36 122.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.0 111.087 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -100.44 176.29 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.433 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -170.09 -169.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.72 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -91.14 45.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.167 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -117.4 32.65 5.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.417 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -98.16 139.91 33.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.835 0.35 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.68 100.76 40.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.13 -32.51 6.76 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 0.0 112.189 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -54.2 -31.4 52.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.313 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 p -128.1 13.56 6.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 111.748 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.85 57.75 7.46 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.138 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.2 p -156.46 169.78 23.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 110.868 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 80.2 m95 -97.76 -178.53 4.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -88.75 -79.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.2 m -166.54 -43.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 56.5 m -51.67 -30.38 21.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.081 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 6' ' ' TRP . 47.6 mm -122.65 155.89 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.43 128.39 25.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 33.5 p90 -105.24 164.21 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.289 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.73 66.18 1.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.552 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.12 -42.18 2.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.51 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 3' ' ' VAL . 9.2 p . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.28 0.562 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -170.21 128.05 0.85 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.015 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -100.21 165.83 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.493 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.6 p-90 -147.41 -161.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.512 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.9 m -95.43 46.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.97 29.13 7.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.595 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -91.49 120.71 32.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.607 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.08 89.78 1.4 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.072 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.86 -18.81 51.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 112.211 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -57.51 -42.03 82.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.0 110.457 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -118.53 13.89 13.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.385 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.8 47.32 18.94 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.006 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.5 p -155.86 155.05 32.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.42 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.8 m95 -86.96 155.6 20.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.785 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -105.43 -41.45 5.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.356 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.7 p -64.79 179.74 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -69.99 -12.3 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.153 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.43 157.73 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 110.709 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.48 123.8 7.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.7 p90 -95.07 162.96 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.34 73.88 0.52 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 -44.5 1.46 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.533 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -58.09 115.21 2.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -91.91 -24.33 19.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -162.41 -162.72 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.427 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 t -96.14 28.7 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.312 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -53.72 -26.98 34.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.687 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 76.4 t80 -54.98 121.02 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -103.28 105.92 48.8 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.98 -36.91 16.38 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.51 2.14 . . . . 0.0 111.915 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -26.56 23.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.274 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -134.54 15.81 3.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.66 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 41.46 51.99 4.5 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.41 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.4 p -154.42 153.12 31.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 41.5 m95 -88.49 -178.56 5.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -123.85 -62.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.084 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.419 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 53.2 m -59.37 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.158 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -70.41 -9.36 56.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.633 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -60.3 155.88 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.736 0.303 . . . . 0.0 110.508 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -47.42 128.66 12.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.295 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.452 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 38.0 p90 -101.46 160.44 14.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.7 -55.28 4.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.91 100.59 0.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.556 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.808 0.337 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.42 126.72 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -99.94 166.09 11.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.822 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.06 -165.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -91.47 43.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.106 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.51 29.79 10.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.08 134.98 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -116.1 93.53 39.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.43 -21.55 53.4 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.33 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.5 -31.12 70.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.1 p -134.35 18.39 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 45.69 59.66 4.73 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.045 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -153.97 160.66 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.352 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.421 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 21.7 m95 -103.3 157.67 16.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -88.96 -73.01 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -52.5 -178.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -75.71 -5.21 44.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.498 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -57.32 159.87 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 110.8 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -45.47 124.53 4.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 111.386 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.5 p90 -96.81 164.27 12.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.961 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.9 -68.03 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.606 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.24 -44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.46 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -141.96 118.06 10.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.99 174.78 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.427 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.1 p-90 -169.92 -164.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.8 p -90.29 44.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -109.17 28.7 10.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.5 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -96.64 130.65 43.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.46 91.54 5.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.04 -22.42 73.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.384 2.056 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -62.07 -35.58 79.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.809 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.74 16.36 11.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.73 46.0 18.43 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.067 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -153.62 163.79 39.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 75.6 m95 -87.24 -178.7 6.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.74 -83.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.396 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -170.09 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.4 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 80.7 p -50.33 -31.8 15.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.146 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.2 mm -123.27 155.45 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.14 129.13 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 44.1 p90 -95.43 169.7 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.39 69.01 1.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.59 -65.06 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.433 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.501 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.669 0.271 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -90.56 147.23 23.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.165 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -100.02 152.91 19.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.443 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 6.2 p-90 -150.36 -154.22 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 m -91.97 35.31 0.98 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.646 0.26 . . . . 0.0 111.39 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.49 28.77 11.92 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.457 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -100.0 127.69 46.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 0.0 110.843 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.5 91.57 2.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 -19.19 62.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.428 2.085 . . . . 0.0 112.534 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -54.96 -33.44 62.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -134.83 15.06 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 111.479 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 64.95 3.65 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.009 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.7 p -156.66 163.37 39.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 80.7 m95 -104.26 157.6 17.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -58.65 -86.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.36 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -170.48 -41.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.299 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' ' 20' ' ' ILE . 29.0 t -50.98 -28.65 10.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.376 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 20' ' ' ILE . 4.1 mp -122.75 151.96 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.771 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.93 131.59 31.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.442 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 46.9 p90 -97.28 174.6 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.94 59.77 2.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.09 -66.22 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.369 -1.24 . . . . 0.0 112.482 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.87 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 111.101 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -153.88 37.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -144.33 134.49 24.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.01 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.07 -178.55 3.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.464 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.4 p-90 -169.48 -152.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.318 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.9 m -90.95 26.57 2.07 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.22 35.2 4.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 73.4 t80 -97.13 123.16 40.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.728 0.299 . . . . 0.0 110.764 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.94 108.01 40.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.996 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -70.36 -34.29 12.85 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.419 2.079 . . . . 0.0 111.724 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -53.66 -29.84 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 p -127.27 14.05 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.674 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.63 27.81 3.27 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -133.3 164.58 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.429 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 95.8 m95 -81.57 -179.14 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -72.8 -82.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.359 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -170.25 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 111.228 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.0 p -52.0 -40.26 60.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.172 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 1.8 mp -101.95 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 105.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -66.81 157.87 31.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.022 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.78 1.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.605 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.54 -84.79 0.99 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.547 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.86 107.07 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -158.29 37.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.092 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -141.7 109.38 5.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -100.06 171.18 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.004 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.457 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.2 p-90 -170.11 -155.92 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -93.99 27.61 2.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.457 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -76.47 -27.94 60.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.563 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -49.49 118.65 2.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.867 0.365 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -102.71 95.06 5.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.56 -21.54 62.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.216 1.944 . . . . 0.0 112.073 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -67.88 -32.04 72.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.0 p -115.99 12.9 15.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.08 31.43 2.09 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.311 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -153.33 148.25 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -70.55 151.34 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.82 -43.54 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.226 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.0 p -65.25 177.59 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.072 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -70.07 -11.59 60.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.269 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.4 mm -57.92 158.73 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.08 122.98 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.126 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -91.64 161.49 14.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.79 -55.93 5.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.76 -115.75 3.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.532 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.276 -1.291 . . . . 0.0 112.482 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.25 134.16 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.445 ' CG2' HG22 ' A' ' 20' ' ' ILE . 35.3 m -100.76 -176.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -74.33 147.03 42.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.021 0.439 . . . . 0.0 111.527 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HG3' ' CH2' ' A' ' 16' ' ' TRP . 29.9 tt0 -100.12 160.57 14.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -167.47 -161.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.65 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -56.55 -18.54 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.37 -28.41 2.2 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.073 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -80.36 117.39 21.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -108.08 92.48 9.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 15.3 Cg_endo -58.35 -19.94 45.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.319 2.013 . . . . 0.0 112.128 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -69.97 -43.51 71.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 p -102.4 13.45 34.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.14 28.0 4.0 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.023 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -148.23 154.35 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.942 0.401 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.458 ' CG ' ' HA ' ' A' ' 22' ' ' TYR . 16.6 m95 -83.17 -176.86 6.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.96 -79.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 t -170.28 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.237 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.7 t -50.48 -37.95 41.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.314 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG22 ' CG2' ' A' ' 3' ' ' VAL . 41.5 mm -119.15 157.88 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.26 133.4 19.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.31 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HA ' ' CG ' ' A' ' 16' ' ' TRP . 43.4 p90 -105.06 163.2 12.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.09 6.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.603 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.61 -93.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.465 179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -138.05 105.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.078 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 m -157.31 32.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.249 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -170.36 114.91 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.043 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -99.97 161.89 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.43 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.2 p-90 -152.73 -152.14 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -94.48 33.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.669 0.271 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -90.58 -30.23 12.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.668 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -54.54 116.02 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.93 107.18 48.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.56 -36.15 20.59 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.463 2.108 . . . . 0.0 111.58 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -54.0 -30.41 47.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.246 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.8 p -119.97 9.9 11.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.786 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.06 29.62 1.58 Allowed Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.247 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.3 p -144.47 152.03 40.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.908 0.385 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 30.1 m95 -81.24 174.73 11.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -131.54 -43.35 1.02 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.425 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 t -65.61 -171.11 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.031 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.3 m -69.54 -12.59 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.231 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG23 ' CZ3' ' A' ' 16' ' ' TRP . 43.8 mm -61.88 152.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.736 0.303 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.26 122.85 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.47 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.8 p90 -91.46 162.64 14.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.213 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 -29.25 12.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.93 113.43 0.44 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.54 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 127.75 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.0 111.085 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 20' ' ' ILE . 35.0 m -149.91 -177.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.034 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -85.16 151.98 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.85 177.69 5.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.452 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.6 p-90 -170.02 -158.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.479 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.8 m -94.77 39.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.7 0.286 . . . . 0.0 111.2 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -94.75 -26.45 13.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.659 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.418 ' HB2' ' CZ2' ' A' ' 16' ' ' TRP . 89.2 t80 -49.56 119.44 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.46 94.51 4.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.8 -15.58 49.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.331 2.021 . . . . 0.0 112.287 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -62.67 -40.81 98.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.7 p -120.64 13.49 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.498 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 48.33 59.35 6.51 Favored Glycine 0 CA--C 1.517 0.212 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.204 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -157.34 175.43 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.0 m95 -113.76 116.09 28.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -68.92 -45.77 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.591 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.6 p -66.37 169.7 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.151 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -63.64 -17.21 62.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 3' ' ' VAL . 38.4 mm -50.85 155.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.936 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.0 125.74 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.884 0.373 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 32.3 p90 -100.8 161.38 13.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.23 59.27 11.0 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.96 -100.81 0.28 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.49 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.56 148.34 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.412 ' CG2' HG22 ' A' ' 20' ' ' ILE . 35.1 m -150.33 -177.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -65.09 137.39 57.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.953 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -100.19 169.78 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -170.02 -155.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 m -75.13 0.61 15.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -49.97 -26.38 8.55 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.853 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.416 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 85.2 t80 -76.42 116.6 17.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 m-20 -112.59 100.81 51.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.988 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 19.7 Cg_endo -59.76 -24.03 74.17 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.291 1.994 . . . . 0.0 112.135 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -59.53 -31.05 69.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -122.31 12.28 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.5 28.13 4.69 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.034 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -150.12 143.08 24.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 69.4 m95 -63.69 177.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.1 mmm180 -81.27 -83.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.414 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.2 p -170.11 -38.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.2 p -47.22 -41.21 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.412 HG22 ' CG2' ' A' ' 3' ' ' VAL . 45.1 mm -118.42 156.33 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.739 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.81 130.6 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 47.5 p90 -94.1 -178.69 4.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.15 41.74 59.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.593 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.85 102.33 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.415 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.531 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -60.64 130.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 m -147.66 178.73 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -82.01 127.29 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.16 158.38 15.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -170.08 -156.37 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.29 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -63.63 -11.69 27.32 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.04 -27.45 3.53 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.194 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.53 117.45 21.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 7.5 m-20 -115.22 102.67 54.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.7 Cg_endo -60.68 -17.21 48.16 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.284 1.989 . . . . 0.0 112.297 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.7 mmp_? -57.03 -31.95 65.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.576 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 p -131.97 13.17 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.42 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.9 35.94 25.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.989 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -147.94 139.94 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.45 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 54.1 m95 -60.9 -175.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.604 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -96.64 -83.66 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.311 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -160.05 -43.17 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.6 m -47.97 -37.46 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.155 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.5 mm -120.05 155.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.69 129.24 19.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.1 p90 -105.87 164.8 11.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.46 . . . . 0.0 111.088 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 53.52 2.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.98 -82.03 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.502 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.366 -0.294 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.38 126.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 111.068 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m -156.92 35.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -170.23 108.23 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -100.2 143.77 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' CE3' ' HB2' ' A' ' 7' ' ' SER . 7.7 p-90 -163.53 -153.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.422 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 49.6 m -64.55 -7.09 9.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.26 -28.74 1.47 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.065 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 91.6 t80 -78.35 120.6 23.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.903 0.382 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.12 98.2 41.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 -23.09 76.43 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.248 1.966 . . . . 0.0 112.068 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -60.35 -38.96 85.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -115.33 13.87 16.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.484 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.21 37.9 8.33 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.137 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.7 p -151.49 156.08 39.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.994 0.426 . . . . 0.0 111.197 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 56.0 m95 -84.48 159.34 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -63.68 -78.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.1 p -170.04 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.157 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -50.95 -30.4 14.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -111.94 147.82 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.664 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.66 95.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.664 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 23.3 p90 -61.75 164.17 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.327 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.67 38.41 7.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.84 -88.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.476 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.37 141.1 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.87 38.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -135.64 138.31 42.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.08 168.62 9.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.42 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.07 -166.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.611 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -90.84 48.45 1.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.076 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -110.45 -28.39 4.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 88.2 t80 -57.48 136.86 56.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -109.19 102.35 48.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.78 -37.57 44.71 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.333 2.022 . . . . 0.0 111.5 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -54.0 -28.88 40.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.265 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.5 p -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.94 48.56 6.28 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.421 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.7 p -156.31 151.8 26.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 63.2 m95 -86.9 164.33 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.1 mmp_? -62.66 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 t -170.19 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.6 t -55.97 -37.2 68.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 2.0 mp -103.76 148.91 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.42 131.65 48.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.6 p90 -95.03 161.88 13.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.007 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.4 48.72 1.8 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.41 33.38 39.47 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.494 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.8 127.14 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -154.51 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -133.94 131.78 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.815 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.37 174.95 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.432 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -170.01 -164.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -89.91 44.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 111.225 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.92 32.56 5.92 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.458 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -99.52 123.62 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -101.96 91.74 2.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.054 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.04 -22.04 73.5 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 112.12 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -62.32 -36.08 81.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.742 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.32 16.76 11.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.509 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.77 46.67 18.87 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.985 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 50.1 p -154.66 157.36 38.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 90.0 m95 -78.46 -177.59 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.98 -83.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.254 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.1 m -169.22 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.1 m -50.38 -36.62 33.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.368 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.6 mm -114.12 156.77 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.75 123.39 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.097 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 42.2 p90 -85.91 162.57 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 72.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.547 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.53 -46.98 1.09 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.591 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.567 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.6 p -97.92 159.0 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -155.3 42.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 111.526 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -153.02 104.24 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -100.5 162.59 12.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 6.1 p-90 -160.57 -153.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.146 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -95.21 38.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -93.26 -29.38 10.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.793 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -53.6 113.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.92 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.58 109.0 51.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.27 -38.85 25.16 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.842 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -51.49 -47.37 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.074 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p -101.91 9.47 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.862 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.97 30.08 0.96 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.372 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 p -145.48 152.56 39.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.292 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 27.9 m95 -76.81 160.4 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -116.47 -31.63 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.7 p -78.66 -175.58 4.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -67.56 -17.36 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.421 HG22 ' CZ3' ' A' ' 16' ' ' TRP . 24.7 mm -56.89 149.43 3.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.766 0.317 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 120.19 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 111.179 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 40.1 p90 -83.62 165.82 18.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.139 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.13 27.53 62.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.97 151.36 5.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.494 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.14 128.84 26.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.4 m -115.18 -174.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.32 171.68 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.2 171.13 9.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.432 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -169.96 -165.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.577 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -90.04 46.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -114.93 29.82 7.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.593 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -95.69 126.26 40.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.749 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -106.92 103.64 48.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.67 -38.67 30.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.372 2.048 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -53.15 -29.41 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.164 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.5 p -119.97 11.17 11.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.706 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.77 29.12 1.88 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.171 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -147.54 155.57 41.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 84.9 m95 -69.22 -176.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -80.57 -77.28 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -170.12 -40.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.405 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 80.2 p -51.15 -31.71 20.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.3 mm -117.33 157.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.02 112.15 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.232 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 46.9 p90 -65.46 152.24 44.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.37 53.38 46.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.43 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.8 113.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.447 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.537 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.23 147.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 0.0 111.031 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.423 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.4 m -148.4 -177.47 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.02 129.07 38.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.22 176.46 5.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.438 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.7 p-90 -170.01 -154.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -93.6 23.46 4.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.671 0.272 . . . . 0.0 111.43 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -69.71 -33.8 71.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.488 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t80 -58.19 125.38 22.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.432 . . . . 0.0 111.09 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.7 95.0 39.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.02 -13.55 38.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.638 2.226 . . . . 0.0 112.952 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -60.74 -33.89 73.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.606 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 t -138.42 17.87 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.79 67.99 1.58 Allowed Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.971 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 p -154.24 169.14 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.242 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.474 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 16.7 m95 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.58 -66.34 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.349 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.6 t -58.57 -175.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.2 m -81.32 -0.64 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.426 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.423 HG23 ' CG2' ' A' ' 3' ' ' VAL . 39.3 mm -61.55 160.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.511 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' N ' HG21 ' A' ' 20' ' ' ILE . . . -45.7 123.3 4.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 111.159 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 27.5 p90 -103.94 172.91 6.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.281 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 49.26 58.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.559 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 -72.97 0.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.49 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.4 t -83.64 126.91 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.8 m -146.39 -178.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -101.52 -177.08 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -98.06 -179.36 4.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.481 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.7 p-90 -167.92 -155.61 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 25.59 3.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.669 0.271 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -77.3 -31.64 50.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.511 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.426 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 90.2 t80 -47.96 116.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.274 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.46 95.77 4.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.058 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.03 -16.6 55.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.233 1.955 . . . . 0.0 112.236 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.36 -36.66 80.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.3 p -122.92 12.26 9.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.271 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.85 51.81 42.88 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.935 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.9 p -157.13 -177.86 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.426 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 77.1 m95 -110.14 156.32 20.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 74.9 mtp180 -60.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.555 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.9 t -170.33 -39.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t -45.81 -33.53 3.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.412 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 mm -125.63 155.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.819 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.92 132.96 32.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.294 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.3 p90 -97.38 179.1 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.82 -55.92 4.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.42 -88.99 0.94 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.467 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 158.13 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.278 . . . . 0.0 110.85 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.96 39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 111.616 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.36 122.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.0 111.087 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -100.44 176.29 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.433 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -170.09 -169.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.72 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -91.14 45.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.167 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -117.4 32.65 5.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.417 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -98.16 139.91 33.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.835 0.35 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.68 100.76 40.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.13 -32.51 6.76 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 0.0 112.189 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -54.2 -31.4 52.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.313 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 p -128.1 13.56 6.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 111.748 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.85 57.75 7.46 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.138 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.2 p -156.46 169.78 23.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 110.868 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 80.2 m95 -97.76 -178.53 4.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -88.75 -79.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.2 m -166.54 -43.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 56.5 m -51.67 -30.38 21.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.081 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 6' ' ' TRP . 47.6 mm -122.65 155.89 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.43 128.39 25.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.016 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 33.5 p90 -105.24 164.21 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.289 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.73 66.18 1.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.552 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.12 -42.18 2.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.51 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.85 137.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.979 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 3' ' ' VAL . 9.2 p -170.09 33.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -170.21 128.05 0.85 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.015 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -100.21 165.83 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.493 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.6 p-90 -147.41 -161.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.512 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.9 m -95.43 46.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.493 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.97 29.13 7.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.595 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -91.49 120.71 32.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.607 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.08 89.78 1.4 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.072 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.86 -18.81 51.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 112.211 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -57.51 -42.03 82.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.0 110.457 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -118.53 13.89 13.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.385 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.8 47.32 18.94 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.006 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.5 p -155.86 155.05 32.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.8 m95 -86.96 155.6 20.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.785 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -105.43 -41.45 5.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.356 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.7 p -64.79 179.74 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -69.99 -12.3 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.153 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.43 157.73 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 110.709 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.48 123.8 7.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.7 p90 -95.07 162.96 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.34 73.88 0.52 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 -44.5 1.46 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.533 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.85 129.94 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -152.57 162.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -58.09 115.21 2.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -91.91 -24.33 19.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.447 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -162.41 -162.72 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.427 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 t -96.14 28.7 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.312 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -53.72 -26.98 34.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.687 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 76.4 t80 -54.98 121.02 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -103.28 105.92 48.8 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -67.98 -36.91 16.38 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.51 2.14 . . . . 0.0 111.915 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.71 -26.56 23.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.274 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -134.54 15.81 3.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.66 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 41.46 51.99 4.5 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.41 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.4 p -154.42 153.12 31.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 41.5 m95 -88.49 -178.56 5.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -123.85 -62.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.084 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.419 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 53.2 m -59.37 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.158 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -70.41 -9.36 56.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.633 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -60.3 155.88 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.736 0.303 . . . . 0.0 110.508 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -47.42 128.66 12.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.295 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.452 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 38.0 p90 -101.46 160.44 14.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.7 -55.28 4.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.91 100.59 0.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.556 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.01 165.75 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 111.177 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m -149.71 -175.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.42 126.72 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -99.94 166.09 11.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.822 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.06 -165.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -91.47 43.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.106 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.51 29.79 10.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.08 134.98 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -116.1 93.53 39.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.43 -21.55 53.4 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.33 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.5 -31.12 70.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.1 p -134.35 18.39 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 45.69 59.66 4.73 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.045 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -153.97 160.66 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.352 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.421 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 21.7 m95 -103.3 157.67 16.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -88.96 -73.01 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -52.5 -178.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -75.71 -5.21 44.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.498 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -57.32 159.87 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 110.8 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' HG23 ' A' ' 20' ' ' ILE . . . -45.47 124.53 4.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 111.386 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.5 p90 -96.81 164.27 12.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.961 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.9 -68.03 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.606 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.24 -44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.46 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.67 129.01 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -153.87 37.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.989 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -141.96 118.06 10.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.99 174.78 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.427 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.1 p-90 -169.92 -164.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.8 p -90.29 44.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -109.17 28.7 10.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.5 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -96.64 130.65 43.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.46 91.54 5.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.04 -22.42 73.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.384 2.056 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -62.07 -35.58 79.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.809 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.74 16.36 11.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.73 46.0 18.43 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.067 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -153.62 163.79 39.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.425 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 75.6 m95 -87.24 -178.7 6.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.74 -83.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.396 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -170.09 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.4 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 80.7 p -50.33 -31.8 15.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.146 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.2 mm -123.27 155.45 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.14 129.13 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 44.1 p90 -95.43 169.7 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.39 69.01 1.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.59 -65.06 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.433 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.501 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.2 139.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.95 -175.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -90.56 147.23 23.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.165 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -100.02 152.91 19.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.443 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 6.2 p-90 -150.36 -154.22 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 m -91.97 35.31 0.98 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.646 0.26 . . . . 0.0 111.39 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.49 28.77 11.92 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.457 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -100.0 127.69 46.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 0.0 110.843 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.5 91.57 2.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 -19.19 62.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.428 2.085 . . . . 0.0 112.534 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -54.96 -33.44 62.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -134.83 15.06 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 111.479 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 64.95 3.65 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.009 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.7 p -156.66 163.37 39.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 80.7 m95 -104.26 157.6 17.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -58.65 -86.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.36 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -170.48 -41.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.299 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' ' 20' ' ' ILE . 29.0 t -50.98 -28.65 10.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.376 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 20' ' ' ILE . 4.1 mp -122.75 151.96 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.771 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.93 131.59 31.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 46.9 p90 -97.28 174.6 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.94 59.77 2.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.09 -66.22 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.369 -1.24 . . . . 0.0 112.482 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.943 0.401 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -144.33 134.49 24.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.01 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.07 -178.55 3.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.4 p-90 -169.48 -152.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.318 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.9 m -90.95 26.57 2.07 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.22 35.2 4.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 73.4 t80 -97.13 123.16 40.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.728 0.299 . . . . 0.0 110.764 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.94 108.01 40.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.996 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -70.36 -34.29 12.85 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.419 2.079 . . . . 0.0 111.724 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -53.66 -29.84 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 p -127.27 14.05 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.674 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.63 27.81 3.27 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -133.3 164.58 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 95.8 m95 -81.57 -179.14 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -72.8 -82.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.359 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -170.25 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 111.228 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 20' ' ' ILE . 30.0 p -52.0 -40.26 60.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.172 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.8 mp -101.95 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 105.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -66.81 157.87 31.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.022 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.78 1.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.605 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.54 -84.79 0.99 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.547 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.925 0.393 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 74.0 mtp180 -141.7 109.38 5.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -100.06 171.18 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.004 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.471 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.2 p-90 -170.11 -155.92 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -93.99 27.61 2.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -76.47 -27.94 60.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.563 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -49.49 118.65 2.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.867 0.365 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 21.6 t70 -102.71 95.06 5.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 17.6 Cg_endo -59.56 -21.54 62.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.216 1.944 . . . . 0.0 112.073 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -67.88 -32.04 72.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.0 p -115.99 12.9 15.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.08 31.43 2.09 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.311 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -153.33 148.25 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -70.55 151.34 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.82 -43.54 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.226 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.0 p -65.25 177.59 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.072 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -70.07 -11.59 60.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.269 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 21' ' ' ALA . 38.4 mm -57.92 158.73 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.08 122.98 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -91.64 161.49 14.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.79 -55.93 5.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.76 -115.75 3.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.532 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.276 -1.291 . . . . 0.0 112.482 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.3 m . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.577 0.227 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -74.33 147.03 42.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.021 0.439 . . . . 0.0 111.527 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HG3' ' CH2' ' A' ' 16' ' ' TRP . 29.9 tt0 -100.12 160.57 14.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.414 ' N ' ' HG2' ' A' ' 5' ' ' GLN . 2.0 p-90 -167.47 -161.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.65 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -56.55 -18.54 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.37 -28.41 2.2 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.073 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -80.36 117.39 21.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -108.08 92.48 9.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 15.3 Cg_endo -58.35 -19.94 45.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.319 2.013 . . . . 0.0 112.128 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -69.97 -43.51 71.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 p -102.4 13.45 34.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.14 28.0 4.0 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.023 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -148.23 154.35 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.942 0.401 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.467 ' CG ' ' HA ' ' A' ' 22' ' ' TYR . 16.6 m95 -83.17 -176.86 6.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.96 -79.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 t -170.28 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.237 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.7 t -50.48 -37.95 41.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.314 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 3' ' ' VAL . 41.5 mm -119.15 157.88 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.26 133.4 19.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.467 ' HA ' ' CG ' ' A' ' 16' ' ' TRP . 43.4 p90 -105.06 163.2 12.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.09 6.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.603 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.61 -93.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' ' CZ2' ' A' ' 16' ' ' TRP . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.465 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 120.964 0.412 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -170.36 114.91 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.043 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -99.97 161.89 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.442 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.2 p-90 -152.73 -152.14 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -94.48 33.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.669 0.271 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -90.58 -30.23 12.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.668 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -54.54 116.02 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.93 107.18 48.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.56 -36.15 20.59 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.463 2.108 . . . . 0.0 111.58 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -54.0 -30.41 47.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.246 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.8 p -119.97 9.9 11.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.786 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.06 29.62 1.58 Allowed Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.247 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.3 p -144.47 152.03 40.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.908 0.385 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 30.1 m95 -81.24 174.73 11.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -131.54 -43.35 1.02 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.425 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 t -65.61 -171.11 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.031 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.3 m -69.54 -12.59 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.231 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 16' ' ' TRP . 43.8 mm -61.88 152.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.736 0.303 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.26 122.85 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.8 p90 -91.46 162.64 14.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.213 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 -29.25 12.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.93 113.43 0.44 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.54 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 20' ' ' ILE . 35.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -85.16 151.98 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.85 177.69 5.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.6 p-90 -170.02 -158.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.479 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.8 m -94.77 39.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.7 0.286 . . . . 0.0 111.2 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -94.75 -26.45 13.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.659 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 16' ' ' TRP . 89.2 t80 -49.56 119.44 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.46 94.51 4.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.8 -15.58 49.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.331 2.021 . . . . 0.0 112.287 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -62.67 -40.81 98.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.7 p -120.64 13.49 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.498 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 48.33 59.35 6.51 Favored Glycine 0 CA--C 1.517 0.212 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.204 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -157.34 175.43 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.474 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.0 m95 -113.76 116.09 28.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -68.92 -45.77 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.591 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.6 p -66.37 169.7 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.151 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -63.64 -17.21 62.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 3' ' ' VAL . 38.4 mm -50.85 155.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.936 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.0 125.74 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.884 0.373 . . . . 0.0 111.242 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 32.3 p90 -100.8 161.38 13.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.23 59.27 11.0 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.96 -100.81 0.28 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.49 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.1 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -65.09 137.39 57.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.953 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -100.19 169.78 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -170.02 -155.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 m -75.13 0.61 15.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -49.97 -26.38 8.55 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.853 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 85.2 t80 -76.42 116.6 17.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 m-20 -112.59 100.81 51.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.988 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 19.7 Cg_endo -59.76 -24.03 74.17 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.291 1.994 . . . . 0.0 112.135 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -59.53 -31.05 69.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -122.31 12.28 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.5 28.13 4.69 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.034 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -150.12 143.08 24.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 69.4 m95 -63.69 177.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 17' ' ' ARG . 24.1 mmm180 -81.27 -83.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.414 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.2 p -170.11 -38.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.2 p -47.22 -41.21 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 21' ' ' ALA . 45.1 mm -118.42 156.33 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.739 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -50.81 130.6 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.466 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 47.5 p90 -94.1 -178.69 4.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.15 41.74 59.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.593 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.85 102.33 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.415 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.531 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.822 0.344 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -82.01 127.29 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.16 158.38 15.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -170.08 -156.37 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.29 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -63.63 -11.69 27.32 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.04 -27.45 3.53 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.194 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.53 117.45 21.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 7.5 m-20 -115.22 102.67 54.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.7 Cg_endo -60.68 -17.21 48.16 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.284 1.989 . . . . 0.0 112.297 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.7 mmp_? -57.03 -31.95 65.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.576 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 p -131.97 13.17 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.42 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.9 35.94 25.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.989 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -147.94 139.94 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 54.1 m95 -60.9 -175.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.604 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -96.64 -83.66 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.311 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -160.05 -43.17 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.6 m -47.97 -37.46 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.155 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 21' ' ' ALA . 42.5 mm -120.05 155.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.69 129.24 19.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.1 p90 -105.87 164.8 11.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.46 . . . . 0.0 111.088 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 53.52 2.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.98 -82.03 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.502 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -170.23 108.23 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 10.2 tt0 -100.2 143.77 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 7' ' ' SER . 7.7 p-90 -163.53 -153.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.415 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 49.6 m -64.55 -7.09 9.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.26 -28.74 1.47 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.065 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 91.6 t80 -78.35 120.6 23.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.903 0.382 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -112.12 98.2 41.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.0 Cg_endo -61.23 -23.09 76.43 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.248 1.966 . . . . 0.0 112.068 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -60.35 -38.96 85.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -115.33 13.87 16.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.484 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.21 37.9 8.33 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.137 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.7 p -151.49 156.08 39.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.994 0.426 . . . . 0.0 111.197 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 56.0 m95 -84.48 159.34 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -63.68 -78.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.1 p -170.04 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.157 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -50.95 -30.4 14.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 57.3 mt -111.94 147.82 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.66 95.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.664 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 23.3 p90 -61.75 164.17 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.327 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.67 38.41 7.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.84 -88.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.476 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.838 0.352 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -135.64 138.31 42.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.08 168.62 9.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.452 ' NE1' HD13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -170.07 -166.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.611 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -90.84 48.45 1.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.076 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -110.45 -28.39 4.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 88.2 t80 -57.48 136.86 56.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -109.19 102.35 48.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.78 -37.57 44.71 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.333 2.022 . . . . 0.0 111.5 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -54.0 -28.88 40.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.265 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.5 p -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.94 48.56 6.28 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.421 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.7 p -156.31 151.8 26.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 63.2 m95 -86.9 164.33 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.1 mmp_? -62.66 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 t -170.19 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.6 t -55.97 -37.2 68.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -103.76 148.91 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.42 131.65 48.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.6 p90 -95.03 161.88 13.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.007 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.4 48.72 1.8 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.41 33.38 39.47 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.494 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.991 0.424 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -133.94 131.78 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.815 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.37 174.95 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -170.01 -164.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -89.91 44.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 111.225 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.92 32.56 5.92 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.458 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -99.52 123.62 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -101.96 91.74 2.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.054 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.04 -22.04 73.5 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 112.12 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -62.32 -36.08 81.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.742 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.32 16.76 11.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.509 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.77 46.67 18.87 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.985 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 50.1 p -154.66 157.36 38.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 90.0 m95 -78.46 -177.59 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.98 -83.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.254 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.1 m -169.22 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.1 m -50.38 -36.62 33.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.368 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.6 mm -114.12 156.77 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.75 123.39 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.097 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 42.2 p90 -85.91 162.57 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 72.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.547 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.53 -46.98 1.09 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.591 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.567 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.79 0.328 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -153.02 104.24 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -100.5 162.59 12.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 6.1 p-90 -160.57 -153.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.146 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -95.21 38.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -93.26 -29.38 10.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.793 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -53.6 113.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.92 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.58 109.0 51.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.27 -38.85 25.16 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.842 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -51.49 -47.37 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.074 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p -101.91 9.47 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.862 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.97 30.08 0.96 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.372 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 p -145.48 152.56 39.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.292 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.458 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 27.9 m95 -76.81 160.4 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -116.47 -31.63 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.7 p -78.66 -175.58 4.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -67.56 -17.36 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.432 HG21 ' CZ3' ' A' ' 16' ' ' TRP . 24.7 mm -56.89 149.43 3.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.766 0.317 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 120.19 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 111.179 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 40.1 p90 -83.62 165.82 18.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.139 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.13 27.53 62.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.97 151.36 5.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.494 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.699 0.285 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -139.32 171.68 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.822 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.2 171.13 9.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -169.96 -165.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.577 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -90.04 46.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -114.93 29.82 7.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.593 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -95.69 126.26 40.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.749 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -106.92 103.64 48.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.67 -38.67 30.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.372 2.048 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -53.15 -29.41 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.164 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.5 p -119.97 11.17 11.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.706 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.77 29.12 1.88 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.171 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -147.54 155.57 41.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 84.9 m95 -69.22 -176.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -80.57 -77.28 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -170.12 -40.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -51.15 -31.71 20.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -117.33 157.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -54.02 112.15 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.232 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 46.9 p90 -65.46 152.24 44.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.37 53.38 46.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.43 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.8 113.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.447 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.537 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.4 m . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.844 0.354 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.02 129.07 38.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.22 176.46 5.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.7 p-90 -170.01 -154.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -93.6 23.46 4.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.671 0.272 . . . . 0.0 111.43 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -69.71 -33.8 71.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.488 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t80 -58.19 125.38 22.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.432 . . . . 0.0 111.09 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.7 95.0 39.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.02 -13.55 38.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.638 2.226 . . . . 0.0 112.952 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -60.74 -33.89 73.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.606 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 t -138.42 17.87 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.79 67.99 1.58 Allowed Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.971 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 p -154.24 169.14 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.242 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 16.7 m95 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.58 -66.34 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.349 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.6 t -58.57 -175.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.2 m -81.32 -0.64 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.426 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.3 mm -61.55 160.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.511 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.7 123.3 4.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 111.159 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.487 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 27.5 p90 -103.94 172.91 6.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.281 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 49.26 58.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.559 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 -72.97 0.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.49 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.819 0.342 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -101.52 -177.08 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -98.06 -179.36 4.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.7 p-90 -167.92 -155.61 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 25.59 3.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.669 0.271 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -77.3 -31.64 50.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.511 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.441 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 90.2 t80 -47.96 116.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.274 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.46 95.77 4.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.058 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.03 -16.6 55.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.233 1.955 . . . . 0.0 112.236 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.36 -36.66 80.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.3 p -122.92 12.26 9.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.271 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.85 51.81 42.88 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.935 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.9 p -157.13 -177.86 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 77.1 m95 -110.14 156.32 20.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 74.9 mtp180 -60.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.555 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.9 t -170.33 -39.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t -45.81 -33.53 3.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.412 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.6 mm -125.63 155.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.819 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.92 132.96 32.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.3 p90 -97.38 179.1 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.82 -55.92 4.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.42 -88.99 0.94 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.467 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.848 0.356 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.36 122.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.0 111.087 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -100.44 176.29 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.445 ' CD1' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -170.09 -169.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.72 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -91.14 45.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.167 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -117.4 32.65 5.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.417 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -98.16 139.91 33.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.835 0.35 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.68 100.76 40.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.13 -32.51 6.76 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 0.0 112.189 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -54.2 -31.4 52.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.313 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 p -128.1 13.56 6.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 111.748 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.85 57.75 7.46 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.138 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.2 p -156.46 169.78 23.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 110.868 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 22' ' ' TYR . 80.2 m95 -97.76 -178.53 4.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -88.75 -79.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.2 m -166.54 -43.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 56.5 m -51.67 -30.38 21.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.081 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' CD1' ' A' ' 6' ' ' TRP . 47.6 mm -122.65 155.89 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.43 128.39 25.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.016 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 16' ' ' TRP . 33.5 p90 -105.24 164.21 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.289 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.73 66.18 1.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.552 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.12 -42.18 2.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.51 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 3' ' ' VAL . 9.2 p . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.28 0.562 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -170.21 128.05 0.85 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.015 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -100.21 165.83 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.6 p-90 -147.41 -161.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.512 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.9 m -95.43 46.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.97 29.13 7.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.595 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -91.49 120.71 32.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.607 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.08 89.78 1.4 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.072 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.86 -18.81 51.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 112.211 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -57.51 -42.03 82.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.0 110.457 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -118.53 13.89 13.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.385 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.8 47.32 18.94 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.006 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.5 p -155.86 155.05 32.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.8 m95 -86.96 155.6 20.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.785 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -105.43 -41.45 5.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.356 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.7 p -64.79 179.74 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -69.99 -12.3 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.153 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 21' ' ' ALA . 49.9 mm -60.43 157.73 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.48 123.8 7.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.7 p90 -95.07 162.96 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.34 73.88 0.52 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 -44.5 1.46 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.533 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -58.09 115.21 2.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -91.91 -24.33 19.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.463 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -162.41 -162.72 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.427 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 t -96.14 28.7 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.312 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -53.72 -26.98 34.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.687 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 76.4 t80 -54.98 121.02 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -103.28 105.92 48.8 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.403 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 11.8 Cg_exo -67.98 -36.91 16.38 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.51 2.14 . . . . 0.0 111.915 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -53.71 -26.56 23.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.274 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -134.54 15.81 3.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.66 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 41.46 51.99 4.5 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.41 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.4 p -154.42 153.12 31.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 41.5 m95 -88.49 -178.56 5.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -123.85 -62.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.084 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.419 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 53.2 m -59.37 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.158 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -70.41 -9.36 56.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.633 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.7 mp -60.3 155.88 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.736 0.303 . . . . 0.0 110.508 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -47.42 128.66 12.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.295 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 38.0 p90 -101.46 160.44 14.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.7 -55.28 4.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.91 100.59 0.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.556 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.808 0.337 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.42 126.72 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -99.94 166.09 11.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.822 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.06 -165.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -91.47 43.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.106 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.51 29.79 10.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.08 134.98 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -116.1 93.53 39.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.43 -21.55 53.4 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.33 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.5 -31.12 70.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.1 p -134.35 18.39 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 45.69 59.66 4.73 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.045 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -153.97 160.66 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.352 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.434 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 21.7 m95 -103.3 157.67 16.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -88.96 -73.01 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -52.5 -178.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -75.71 -5.21 44.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.498 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -57.32 159.87 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 110.8 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.47 124.53 4.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 111.386 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.5 p90 -96.81 164.27 12.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.961 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.9 -68.03 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.606 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.24 -44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.46 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -141.96 118.06 10.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.99 174.78 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.1 p-90 -169.92 -164.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.8 p -90.29 44.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -109.17 28.7 10.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.5 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -96.64 130.65 43.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.46 91.54 5.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.04 -22.42 73.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.384 2.056 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -62.07 -35.58 79.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.809 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.74 16.36 11.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.73 46.0 18.43 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.067 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -153.62 163.79 39.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.435 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 75.6 m95 -87.24 -178.7 6.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.74 -83.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.396 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -170.09 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.7 p -50.33 -31.8 15.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.146 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.2 mm -123.27 155.45 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -53.14 129.13 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 44.1 p90 -95.43 169.7 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.39 69.01 1.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.59 -65.06 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.433 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.501 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.669 0.271 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -90.56 147.23 23.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.165 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -100.02 152.91 19.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.443 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 6.2 p-90 -150.36 -154.22 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 m -91.97 35.31 0.98 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.646 0.26 . . . . 0.0 111.39 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.49 28.77 11.92 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.457 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -100.0 127.69 46.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 0.0 110.843 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.5 91.57 2.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 -19.19 62.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.428 2.085 . . . . 0.0 112.534 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -54.96 -33.44 62.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -134.83 15.06 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 111.479 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 64.95 3.65 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.009 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.7 p -156.66 163.37 39.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 80.7 m95 -104.26 157.6 17.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -58.65 -86.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.36 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -170.48 -41.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.299 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -50.98 -28.65 10.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.376 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -122.75 151.96 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.771 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.93 131.59 31.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 46.9 p90 -97.28 174.6 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.94 59.77 2.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.09 -66.22 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.369 -1.24 . . . . 0.0 112.482 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.87 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 111.101 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -153.88 37.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -144.33 134.49 24.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.01 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.07 -178.55 3.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.4 p-90 -169.48 -152.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.318 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.9 m -90.95 26.57 2.07 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.22 35.2 4.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 73.4 t80 -97.13 123.16 40.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.728 0.299 . . . . 0.0 110.764 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.94 108.01 40.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.996 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -70.36 -34.29 12.85 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.419 2.079 . . . . 0.0 111.724 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -53.66 -29.84 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 p -127.27 14.05 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.674 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.63 27.81 3.27 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -133.3 164.58 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 95.8 m95 -81.57 -179.14 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -72.8 -82.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.359 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -170.25 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 111.228 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 20' ' ' ILE . 30.0 p -52.0 -40.26 60.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.172 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.8 mp -101.95 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 105.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -66.81 157.87 31.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.022 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.78 1.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.605 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.54 -84.79 0.99 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.547 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.1 p -139.86 107.07 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 2' ' ' VAL . 27.7 m -158.29 37.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.092 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 74.0 mtp180 -141.7 109.38 5.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -100.06 171.18 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.004 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.471 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.2 p-90 -170.11 -155.92 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -93.99 27.61 2.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -76.47 -27.94 60.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.563 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -49.49 118.65 2.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.867 0.365 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 21.6 t70 -102.71 95.06 5.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 17.6 Cg_endo -59.56 -21.54 62.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.216 1.944 . . . . 0.0 112.073 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -67.88 -32.04 72.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.0 p -115.99 12.9 15.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.08 31.43 2.09 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.311 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -153.33 148.25 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -70.55 151.34 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.82 -43.54 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.226 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.0 p -65.25 177.59 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.072 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -70.07 -11.59 60.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.269 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 21' ' ' ALA . 38.4 mm -57.92 158.73 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.08 122.98 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -91.64 161.49 14.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.79 -55.93 5.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.76 -115.75 3.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.532 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.276 -1.291 . . . . 0.0 112.482 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.25 134.16 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.3 m -100.76 -176.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -74.33 147.03 42.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.021 0.439 . . . . 0.0 111.527 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HG3' ' CH2' ' A' ' 16' ' ' TRP . 29.9 tt0 -100.12 160.57 14.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.414 ' N ' ' HG2' ' A' ' 5' ' ' GLN . 2.0 p-90 -167.47 -161.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.65 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -56.55 -18.54 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.37 -28.41 2.2 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.073 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -80.36 117.39 21.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -108.08 92.48 9.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 15.3 Cg_endo -58.35 -19.94 45.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.319 2.013 . . . . 0.0 112.128 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -69.97 -43.51 71.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 p -102.4 13.45 34.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.14 28.0 4.0 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.023 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -148.23 154.35 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.942 0.401 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.467 ' CG ' ' HA ' ' A' ' 22' ' ' TYR . 16.6 m95 -83.17 -176.86 6.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.96 -79.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 t -170.28 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.237 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.7 t -50.48 -37.95 41.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.314 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 3' ' ' VAL . 41.5 mm -119.15 157.88 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.26 133.4 19.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.467 ' HA ' ' CG ' ' A' ' 16' ' ' TRP . 43.4 p90 -105.06 163.2 12.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.09 6.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.603 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.61 -93.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' ' CZ2' ' A' ' 16' ' ' TRP . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.465 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 2' ' ' VAL . 7.8 p -138.05 105.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 2' ' ' VAL . 23.9 m -157.31 32.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.249 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -170.36 114.91 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.043 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -99.97 161.89 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.442 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.2 p-90 -152.73 -152.14 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -94.48 33.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.669 0.271 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -90.58 -30.23 12.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.668 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -54.54 116.02 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.93 107.18 48.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.56 -36.15 20.59 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.463 2.108 . . . . 0.0 111.58 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -54.0 -30.41 47.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.246 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.8 p -119.97 9.9 11.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.786 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.06 29.62 1.58 Allowed Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.247 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.3 p -144.47 152.03 40.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.908 0.385 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 30.1 m95 -81.24 174.73 11.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -131.54 -43.35 1.02 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.425 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 t -65.61 -171.11 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.031 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.3 m -69.54 -12.59 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.231 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 16' ' ' TRP . 43.8 mm -61.88 152.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.736 0.303 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.26 122.85 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.8 p90 -91.46 162.64 14.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.213 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 -29.25 12.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.93 113.43 0.44 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.54 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 127.75 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.0 111.085 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 20' ' ' ILE . 35.0 m -149.91 -177.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.034 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -85.16 151.98 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.85 177.69 5.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.6 p-90 -170.02 -158.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.479 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.8 m -94.77 39.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.7 0.286 . . . . 0.0 111.2 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -94.75 -26.45 13.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.659 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 16' ' ' TRP . 89.2 t80 -49.56 119.44 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.46 94.51 4.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.8 -15.58 49.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.331 2.021 . . . . 0.0 112.287 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -62.67 -40.81 98.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.7 p -120.64 13.49 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.498 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 48.33 59.35 6.51 Favored Glycine 0 CA--C 1.517 0.212 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.204 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -157.34 175.43 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.474 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.0 m95 -113.76 116.09 28.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -68.92 -45.77 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.591 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.6 p -66.37 169.7 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.151 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -63.64 -17.21 62.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 3' ' ' VAL . 38.4 mm -50.85 155.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.936 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.0 125.74 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.884 0.373 . . . . 0.0 111.242 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 32.3 p90 -100.8 161.38 13.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.23 59.27 11.0 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.96 -100.81 0.28 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.49 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.56 148.34 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.1 m -150.33 -177.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -65.09 137.39 57.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.953 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -100.19 169.78 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -170.02 -155.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 m -75.13 0.61 15.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -49.97 -26.38 8.55 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.853 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 85.2 t80 -76.42 116.6 17.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 m-20 -112.59 100.81 51.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.988 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 19.7 Cg_endo -59.76 -24.03 74.17 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.291 1.994 . . . . 0.0 112.135 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -59.53 -31.05 69.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -122.31 12.28 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.5 28.13 4.69 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.034 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -150.12 143.08 24.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 69.4 m95 -63.69 177.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 17' ' ' ARG . 24.1 mmm180 -81.27 -83.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.414 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.2 p -170.11 -38.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.2 p -47.22 -41.21 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 21' ' ' ALA . 45.1 mm -118.42 156.33 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.739 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -50.81 130.6 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.466 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 47.5 p90 -94.1 -178.69 4.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.15 41.74 59.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.593 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.85 102.33 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.415 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.531 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -60.64 130.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 m -147.66 178.73 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -82.01 127.29 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.16 158.38 15.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -170.08 -156.37 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.29 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -63.63 -11.69 27.32 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.04 -27.45 3.53 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.194 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.53 117.45 21.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 7.5 m-20 -115.22 102.67 54.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.7 Cg_endo -60.68 -17.21 48.16 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.284 1.989 . . . . 0.0 112.297 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.7 mmp_? -57.03 -31.95 65.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.576 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 p -131.97 13.17 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.42 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.9 35.94 25.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.989 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -147.94 139.94 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 54.1 m95 -60.9 -175.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.604 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -96.64 -83.66 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.311 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -160.05 -43.17 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.6 m -47.97 -37.46 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.155 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 21' ' ' ALA . 42.5 mm -120.05 155.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.69 129.24 19.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.1 p90 -105.87 164.8 11.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.46 . . . . 0.0 111.088 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 53.52 2.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.98 -82.03 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.502 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.366 -0.294 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 3' ' ' VAL . 9.2 p -142.38 126.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 111.068 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 2' ' ' VAL . 23.8 m -156.92 35.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -170.23 108.23 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 10.2 tt0 -100.2 143.77 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 7' ' ' SER . 7.7 p-90 -163.53 -153.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.415 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 49.6 m -64.55 -7.09 9.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.26 -28.74 1.47 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.065 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 91.6 t80 -78.35 120.6 23.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.903 0.382 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -112.12 98.2 41.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.0 Cg_endo -61.23 -23.09 76.43 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.248 1.966 . . . . 0.0 112.068 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -60.35 -38.96 85.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -115.33 13.87 16.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.484 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.21 37.9 8.33 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.137 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.7 p -151.49 156.08 39.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.994 0.426 . . . . 0.0 111.197 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 56.0 m95 -84.48 159.34 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -63.68 -78.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.1 p -170.04 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.157 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -50.95 -30.4 14.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 57.3 mt -111.94 147.82 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.66 95.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.664 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 23.3 p90 -61.75 164.17 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.327 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.67 38.41 7.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.84 -88.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.476 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.37 141.1 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.87 38.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -135.64 138.31 42.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.08 168.62 9.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.452 ' NE1' HD13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -170.07 -166.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.611 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -90.84 48.45 1.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.076 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -110.45 -28.39 4.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 88.2 t80 -57.48 136.86 56.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -109.19 102.35 48.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.78 -37.57 44.71 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.333 2.022 . . . . 0.0 111.5 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -54.0 -28.88 40.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.265 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.5 p -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.94 48.56 6.28 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.421 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.7 p -156.31 151.8 26.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 63.2 m95 -86.9 164.33 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.1 mmp_? -62.66 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 t -170.19 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.6 t -55.97 -37.2 68.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -103.76 148.91 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.42 131.65 48.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.6 p90 -95.03 161.88 13.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.007 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.4 48.72 1.8 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.41 33.38 39.47 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.494 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.8 127.14 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -154.51 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -133.94 131.78 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.815 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.37 174.95 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -170.01 -164.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -89.91 44.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 111.225 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.92 32.56 5.92 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.458 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -99.52 123.62 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -101.96 91.74 2.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.054 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.04 -22.04 73.5 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 112.12 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -62.32 -36.08 81.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.742 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.32 16.76 11.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.509 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.77 46.67 18.87 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.985 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 50.1 p -154.66 157.36 38.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 90.0 m95 -78.46 -177.59 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.98 -83.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.254 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.1 m -169.22 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.1 m -50.38 -36.62 33.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.368 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.6 mm -114.12 156.77 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.75 123.39 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.097 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 42.2 p90 -85.91 162.57 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 72.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.547 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.53 -46.98 1.09 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.591 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.567 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 3' ' ' VAL . 14.6 p -97.92 159.0 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 110.968 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.469 ' N ' HG22 ' A' ' 2' ' ' VAL . 30.0 m -155.3 42.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 111.526 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -153.02 104.24 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -100.5 162.59 12.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 6.1 p-90 -160.57 -153.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.146 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -95.21 38.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -93.26 -29.38 10.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.793 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -53.6 113.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.92 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.58 109.0 51.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.27 -38.85 25.16 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.842 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -51.49 -47.37 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.074 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p -101.91 9.47 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.862 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.97 30.08 0.96 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.372 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 p -145.48 152.56 39.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.292 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.458 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 27.9 m95 -76.81 160.4 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -116.47 -31.63 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.7 p -78.66 -175.58 4.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -67.56 -17.36 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 HG23 HG21 ' A' ' 2' ' ' VAL . 24.7 mm -56.89 149.43 3.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.766 0.317 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 120.19 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 111.179 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 40.1 p90 -83.62 165.82 18.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.139 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.13 27.53 62.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.97 151.36 5.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.494 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.14 128.84 26.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.4 m -115.18 -174.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -139.32 171.68 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.822 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.2 171.13 9.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -169.96 -165.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.577 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -90.04 46.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -114.93 29.82 7.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.593 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -95.69 126.26 40.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.749 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -106.92 103.64 48.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.67 -38.67 30.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.372 2.048 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -53.15 -29.41 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.164 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.5 p -119.97 11.17 11.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.706 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.77 29.12 1.88 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.171 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -147.54 155.57 41.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 84.9 m95 -69.22 -176.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -80.57 -77.28 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -170.12 -40.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -51.15 -31.71 20.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -117.33 157.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -54.02 112.15 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.232 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 46.9 p90 -65.46 152.24 44.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.37 53.38 46.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.43 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.8 113.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.447 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.537 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.23 147.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 0.0 111.031 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.4 m -148.4 -177.47 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.02 129.07 38.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.22 176.46 5.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.7 p-90 -170.01 -154.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -93.6 23.46 4.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.671 0.272 . . . . 0.0 111.43 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -69.71 -33.8 71.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.488 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t80 -58.19 125.38 22.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.432 . . . . 0.0 111.09 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.7 95.0 39.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.02 -13.55 38.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.638 2.226 . . . . 0.0 112.952 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -60.74 -33.89 73.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.606 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 t -138.42 17.87 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.79 67.99 1.58 Allowed Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.971 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 p -154.24 169.14 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.242 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 16.7 m95 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.58 -66.34 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.349 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.6 t -58.57 -175.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.2 m -81.32 -0.64 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.426 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.3 mm -61.55 160.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.511 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.7 123.3 4.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 111.159 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.487 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 27.5 p90 -103.94 172.91 6.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.281 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 49.26 58.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.559 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 -72.97 0.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.49 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.4 t -83.64 126.91 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.8 m -146.39 -178.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -101.52 -177.08 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -98.06 -179.36 4.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.7 p-90 -167.92 -155.61 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 25.59 3.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.669 0.271 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -77.3 -31.64 50.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.511 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.441 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 90.2 t80 -47.96 116.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.274 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.46 95.77 4.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.058 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.03 -16.6 55.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.233 1.955 . . . . 0.0 112.236 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.36 -36.66 80.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.3 p -122.92 12.26 9.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.271 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.85 51.81 42.88 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.935 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.9 p -157.13 -177.86 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 77.1 m95 -110.14 156.32 20.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 74.9 mtp180 -60.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.555 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.9 t -170.33 -39.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t -45.81 -33.53 3.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.412 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.6 mm -125.63 155.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.819 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.92 132.96 32.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.3 p90 -97.38 179.1 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.82 -55.92 4.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.42 -88.99 0.94 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.467 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 3' ' ' VAL . 11.0 p -67.57 158.13 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.278 . . . . 0.0 110.85 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' N ' HG22 ' A' ' 2' ' ' VAL . 31.1 m -132.96 39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 111.616 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.36 122.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.0 111.087 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -100.44 176.29 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.445 ' CD1' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -170.09 -169.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.72 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -91.14 45.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.167 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -117.4 32.65 5.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.417 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -98.16 139.91 33.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.835 0.35 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.68 100.76 40.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.13 -32.51 6.76 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 0.0 112.189 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -54.2 -31.4 52.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.313 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 p -128.1 13.56 6.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 111.748 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.85 57.75 7.46 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.138 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.2 p -156.46 169.78 23.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 110.868 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 22' ' ' TYR . 80.2 m95 -97.76 -178.53 4.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -88.75 -79.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.2 m -166.54 -43.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 56.5 m -51.67 -30.38 21.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.081 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' CD1' ' A' ' 6' ' ' TRP . 47.6 mm -122.65 155.89 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.43 128.39 25.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.016 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 16' ' ' TRP . 33.5 p90 -105.24 164.21 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.289 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.73 66.18 1.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.552 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.12 -42.18 2.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.51 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.85 137.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.979 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 3' ' ' VAL . 9.2 p -170.09 33.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -170.21 128.05 0.85 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.015 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -100.21 165.83 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.6 p-90 -147.41 -161.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.512 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.9 m -95.43 46.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.97 29.13 7.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.595 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -91.49 120.71 32.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.607 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.08 89.78 1.4 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.072 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.86 -18.81 51.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 112.211 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -57.51 -42.03 82.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.0 110.457 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -118.53 13.89 13.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.385 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.8 47.32 18.94 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.006 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.5 p -155.86 155.05 32.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.8 m95 -86.96 155.6 20.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.785 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -105.43 -41.45 5.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.356 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.7 p -64.79 179.74 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -69.99 -12.3 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.153 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 21' ' ' ALA . 49.9 mm -60.43 157.73 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.48 123.8 7.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.7 p90 -95.07 162.96 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.34 73.88 0.52 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 -44.5 1.46 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.533 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.85 129.94 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -152.57 162.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -58.09 115.21 2.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -91.91 -24.33 19.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.463 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -162.41 -162.72 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.427 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 t -96.14 28.7 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.312 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -53.72 -26.98 34.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.687 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 76.4 t80 -54.98 121.02 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -103.28 105.92 48.8 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.403 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 11.8 Cg_exo -67.98 -36.91 16.38 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.51 2.14 . . . . 0.0 111.915 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -53.71 -26.56 23.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.274 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -134.54 15.81 3.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.66 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 41.46 51.99 4.5 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.41 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.4 p -154.42 153.12 31.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 41.5 m95 -88.49 -178.56 5.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -123.85 -62.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.084 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.419 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 53.2 m -59.37 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.158 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -70.41 -9.36 56.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.633 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.7 mp -60.3 155.88 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.736 0.303 . . . . 0.0 110.508 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -47.42 128.66 12.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.295 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 38.0 p90 -101.46 160.44 14.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.7 -55.28 4.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.91 100.59 0.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.556 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.01 165.75 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 111.177 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m -149.71 -175.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.42 126.72 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -99.94 166.09 11.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.822 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.06 -165.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -91.47 43.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.106 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.51 29.79 10.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.08 134.98 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -116.1 93.53 39.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.43 -21.55 53.4 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.33 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.5 -31.12 70.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.1 p -134.35 18.39 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 45.69 59.66 4.73 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.045 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -153.97 160.66 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.352 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.434 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 21.7 m95 -103.3 157.67 16.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -88.96 -73.01 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -52.5 -178.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -75.71 -5.21 44.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.498 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -57.32 159.87 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 110.8 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.47 124.53 4.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 111.386 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.5 p90 -96.81 164.27 12.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.961 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.9 -68.03 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.606 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.24 -44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.46 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.67 129.01 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -153.87 37.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.989 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -141.96 118.06 10.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.99 174.78 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.1 p-90 -169.92 -164.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.8 p -90.29 44.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -109.17 28.7 10.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.5 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -96.64 130.65 43.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.46 91.54 5.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.04 -22.42 73.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.384 2.056 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -62.07 -35.58 79.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.809 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.74 16.36 11.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.73 46.0 18.43 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.067 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -153.62 163.79 39.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.435 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 75.6 m95 -87.24 -178.7 6.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' NE ' ' HA ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.74 -83.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.396 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -170.09 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.7 p -50.33 -31.8 15.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.146 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.2 mm -123.27 155.45 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -53.14 129.13 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 44.1 p90 -95.43 169.7 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.39 69.01 1.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.59 -65.06 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.433 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.501 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.2 139.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.95 -175.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -90.56 147.23 23.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.165 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -100.02 152.91 19.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.443 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 6.2 p-90 -150.36 -154.22 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 m -91.97 35.31 0.98 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.646 0.26 . . . . 0.0 111.39 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.49 28.77 11.92 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.457 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -100.0 127.69 46.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 0.0 110.843 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.5 91.57 2.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 -19.19 62.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.428 2.085 . . . . 0.0 112.534 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -54.96 -33.44 62.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -134.83 15.06 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 111.479 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 64.95 3.65 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.009 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.7 p -156.66 163.37 39.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 80.7 m95 -104.26 157.6 17.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -58.65 -86.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.36 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -170.48 -41.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.299 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -50.98 -28.65 10.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.376 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -122.75 151.96 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.771 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.93 131.59 31.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 46.9 p90 -97.28 174.6 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.94 59.77 2.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.09 -66.22 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.369 -1.24 . . . . 0.0 112.482 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.943 0.401 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -144.33 134.49 24.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.01 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.07 -178.55 3.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.4 p-90 -169.48 -152.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.318 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.9 m -90.95 26.57 2.07 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.22 35.2 4.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 73.4 t80 -97.13 123.16 40.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.728 0.299 . . . . 0.0 110.764 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.94 108.01 40.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.996 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -70.36 -34.29 12.85 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.419 2.079 . . . . 0.0 111.724 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -53.66 -29.84 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 p -127.27 14.05 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.674 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.63 27.81 3.27 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -133.3 164.58 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 95.8 m95 -81.57 -179.14 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -72.8 -82.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.359 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -170.25 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 111.228 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 20' ' ' ILE . 30.0 p -52.0 -40.26 60.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.172 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.8 mp -101.95 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 105.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -66.81 157.87 31.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.022 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.78 1.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.605 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.54 -84.79 0.99 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.547 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.925 0.393 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 74.0 mtp180 -141.7 109.38 5.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -100.06 171.18 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.004 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.471 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.2 p-90 -170.11 -155.92 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -93.99 27.61 2.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -76.47 -27.94 60.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.563 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -49.49 118.65 2.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.867 0.365 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 21.6 t70 -102.71 95.06 5.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 17.6 Cg_endo -59.56 -21.54 62.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.216 1.944 . . . . 0.0 112.073 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -67.88 -32.04 72.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.0 p -115.99 12.9 15.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.08 31.43 2.09 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.311 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -153.33 148.25 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -70.55 151.34 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.82 -43.54 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.226 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.0 p -65.25 177.59 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.072 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -70.07 -11.59 60.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.269 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 21' ' ' ALA . 38.4 mm -57.92 158.73 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.08 122.98 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -91.64 161.49 14.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.79 -55.93 5.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.76 -115.75 3.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.532 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.276 -1.291 . . . . 0.0 112.482 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.3 m . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.577 0.227 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -74.33 147.03 42.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.021 0.439 . . . . 0.0 111.527 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HG3' ' CH2' ' A' ' 16' ' ' TRP . 29.9 tt0 -100.12 160.57 14.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.414 ' N ' ' HG2' ' A' ' 5' ' ' GLN . 2.0 p-90 -167.47 -161.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.65 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -56.55 -18.54 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.37 -28.41 2.2 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.073 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -80.36 117.39 21.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -108.08 92.48 9.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 15.3 Cg_endo -58.35 -19.94 45.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.319 2.013 . . . . 0.0 112.128 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -69.97 -43.51 71.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 p -102.4 13.45 34.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.14 28.0 4.0 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.023 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -148.23 154.35 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.942 0.401 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.467 ' CG ' ' HA ' ' A' ' 22' ' ' TYR . 16.6 m95 -83.17 -176.86 6.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.96 -79.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 t -170.28 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.237 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.7 t -50.48 -37.95 41.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.314 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 3' ' ' VAL . 41.5 mm -119.15 157.88 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.26 133.4 19.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.467 ' HA ' ' CG ' ' A' ' 16' ' ' TRP . 43.4 p90 -105.06 163.2 12.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.09 6.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.603 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.61 -93.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' ' CZ2' ' A' ' 16' ' ' TRP . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.465 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.9 m . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 120.964 0.412 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -170.36 114.91 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.043 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -99.97 161.89 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.442 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.2 p-90 -152.73 -152.14 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -94.48 33.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.669 0.271 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -90.58 -30.23 12.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.668 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -54.54 116.02 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.93 107.18 48.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.56 -36.15 20.59 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.463 2.108 . . . . 0.0 111.58 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -54.0 -30.41 47.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.246 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.8 p -119.97 9.9 11.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.786 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.06 29.62 1.58 Allowed Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.247 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.3 p -144.47 152.03 40.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.908 0.385 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 30.1 m95 -81.24 174.73 11.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -131.54 -43.35 1.02 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.425 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 t -65.61 -171.11 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.031 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.3 m -69.54 -12.59 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.231 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 16' ' ' TRP . 43.8 mm -61.88 152.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.736 0.303 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.26 122.85 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.8 p90 -91.46 162.64 14.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.213 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 -29.25 12.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.93 113.43 0.44 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.54 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 20' ' ' ILE . 35.0 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.337 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -85.16 151.98 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.85 177.69 5.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.6 p-90 -170.02 -158.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.479 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.8 m -94.77 39.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.7 0.286 . . . . 0.0 111.2 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -94.75 -26.45 13.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.659 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 16' ' ' TRP . 89.2 t80 -49.56 119.44 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.46 94.51 4.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.8 -15.58 49.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.331 2.021 . . . . 0.0 112.287 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -62.67 -40.81 98.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.7 p -120.64 13.49 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.498 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 48.33 59.35 6.51 Favored Glycine 0 CA--C 1.517 0.212 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.204 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -157.34 175.43 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.474 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.0 m95 -113.76 116.09 28.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -68.92 -45.77 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.591 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.6 p -66.37 169.7 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.151 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -63.64 -17.21 62.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 3' ' ' VAL . 38.4 mm -50.85 155.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.936 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.0 125.74 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.884 0.373 . . . . 0.0 111.242 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 32.3 p90 -100.8 161.38 13.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.23 59.27 11.0 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.96 -100.81 0.28 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.49 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.1 m . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.658 0.266 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -65.09 137.39 57.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.953 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -100.19 169.78 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -170.02 -155.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 m -75.13 0.61 15.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -49.97 -26.38 8.55 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.853 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 85.2 t80 -76.42 116.6 17.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 m-20 -112.59 100.81 51.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.988 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 19.7 Cg_endo -59.76 -24.03 74.17 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.291 1.994 . . . . 0.0 112.135 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -59.53 -31.05 69.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -122.31 12.28 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.5 28.13 4.69 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.034 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -150.12 143.08 24.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 69.4 m95 -63.69 177.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.1 mmm180 -81.27 -83.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.414 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.2 p -170.11 -38.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.2 p -47.22 -41.21 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 21' ' ' ALA . 45.1 mm -118.42 156.33 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.739 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -50.81 130.6 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.466 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 47.5 p90 -94.1 -178.69 4.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.15 41.74 59.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.593 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.85 102.33 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.415 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.531 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.822 0.344 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -82.01 127.29 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.16 158.38 15.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -170.08 -156.37 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.29 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -63.63 -11.69 27.32 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.04 -27.45 3.53 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.194 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.53 117.45 21.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 7.5 m-20 -115.22 102.67 54.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.7 Cg_endo -60.68 -17.21 48.16 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.284 1.989 . . . . 0.0 112.297 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.7 mmp_? -57.03 -31.95 65.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.576 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 p -131.97 13.17 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.42 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.9 35.94 25.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.989 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -147.94 139.94 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 54.1 m95 -60.9 -175.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.604 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -96.64 -83.66 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.311 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -160.05 -43.17 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.6 m -47.97 -37.46 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.155 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 21' ' ' ALA . 42.5 mm -120.05 155.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.69 129.24 19.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.1 p90 -105.87 164.8 11.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.46 . . . . 0.0 111.088 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 53.52 2.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.98 -82.03 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.502 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -170.23 108.23 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 10.2 tt0 -100.2 143.77 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 7' ' ' SER . 7.7 p-90 -163.53 -153.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.415 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 49.6 m -64.55 -7.09 9.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.26 -28.74 1.47 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.065 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 91.6 t80 -78.35 120.6 23.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.903 0.382 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -112.12 98.2 41.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.0 Cg_endo -61.23 -23.09 76.43 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.248 1.966 . . . . 0.0 112.068 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -60.35 -38.96 85.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -115.33 13.87 16.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.484 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.21 37.9 8.33 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.137 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.7 p -151.49 156.08 39.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.994 0.426 . . . . 0.0 111.197 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 56.0 m95 -84.48 159.34 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -63.68 -78.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.1 p -170.04 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.157 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -50.95 -30.4 14.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 57.3 mt -111.94 147.82 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.66 95.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.664 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 23.3 p90 -61.75 164.17 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.327 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.67 38.41 7.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.84 -88.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.476 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.838 0.352 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -135.64 138.31 42.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.08 168.62 9.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.452 ' NE1' HD13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -170.07 -166.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.611 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -90.84 48.45 1.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.076 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -110.45 -28.39 4.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 88.2 t80 -57.48 136.86 56.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -109.19 102.35 48.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.78 -37.57 44.71 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.333 2.022 . . . . 0.0 111.5 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -54.0 -28.88 40.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.265 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.5 p -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.94 48.56 6.28 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.421 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.7 p -156.31 151.8 26.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 63.2 m95 -86.9 164.33 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.1 mmp_? -62.66 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 t -170.19 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.6 t -55.97 -37.2 68.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -103.76 148.91 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.42 131.65 48.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.6 p90 -95.03 161.88 13.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.007 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.4 48.72 1.8 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.41 33.38 39.47 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.494 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.991 0.424 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -133.94 131.78 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.815 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.37 174.95 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -170.01 -164.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -89.91 44.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 111.225 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.92 32.56 5.92 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.458 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -99.52 123.62 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -101.96 91.74 2.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.054 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.04 -22.04 73.5 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 112.12 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -62.32 -36.08 81.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.742 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.32 16.76 11.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.509 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.77 46.67 18.87 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.985 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 50.1 p -154.66 157.36 38.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 90.0 m95 -78.46 -177.59 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.98 -83.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.254 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.1 m -169.22 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.1 m -50.38 -36.62 33.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.368 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.6 mm -114.12 156.77 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.75 123.39 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.097 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 42.2 p90 -85.91 162.57 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 72.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.547 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.53 -46.98 1.09 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.591 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.567 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.79 0.328 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -153.02 104.24 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -100.5 162.59 12.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 6.1 p-90 -160.57 -153.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.146 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -95.21 38.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -93.26 -29.38 10.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.793 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -53.6 113.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.92 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.58 109.0 51.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.27 -38.85 25.16 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.842 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -51.49 -47.37 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.074 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p -101.91 9.47 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.862 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.97 30.08 0.96 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.372 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 p -145.48 152.56 39.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.292 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.458 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 27.9 m95 -76.81 160.4 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -116.47 -31.63 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.7 p -78.66 -175.58 4.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -67.56 -17.36 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.432 HG21 ' CZ3' ' A' ' 16' ' ' TRP . 24.7 mm -56.89 149.43 3.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.766 0.317 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 120.19 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 111.179 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 40.1 p90 -83.62 165.82 18.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.139 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.13 27.53 62.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.97 151.36 5.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.494 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.699 0.285 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -139.32 171.68 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.822 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.2 171.13 9.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -169.96 -165.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.577 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -90.04 46.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -114.93 29.82 7.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.593 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -95.69 126.26 40.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.749 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -106.92 103.64 48.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.67 -38.67 30.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.372 2.048 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -53.15 -29.41 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.164 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.5 p -119.97 11.17 11.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.706 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.77 29.12 1.88 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.171 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -147.54 155.57 41.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 84.9 m95 -69.22 -176.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -80.57 -77.28 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -170.12 -40.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -51.15 -31.71 20.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -117.33 157.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -54.02 112.15 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.232 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 46.9 p90 -65.46 152.24 44.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.37 53.38 46.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.43 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.8 113.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.447 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.537 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.4 m . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.844 0.354 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.02 129.07 38.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.22 176.46 5.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.7 p-90 -170.01 -154.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -93.6 23.46 4.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.671 0.272 . . . . 0.0 111.43 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -69.71 -33.8 71.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.488 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t80 -58.19 125.38 22.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.432 . . . . 0.0 111.09 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.7 95.0 39.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.02 -13.55 38.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.638 2.226 . . . . 0.0 112.952 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -60.74 -33.89 73.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.606 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 t -138.42 17.87 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.79 67.99 1.58 Allowed Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.971 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 p -154.24 169.14 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.242 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 16.7 m95 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.58 -66.34 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.349 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.6 t -58.57 -175.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.2 m -81.32 -0.64 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.426 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.3 mm -61.55 160.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.511 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.7 123.3 4.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 111.159 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.487 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 27.5 p90 -103.94 172.91 6.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.281 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 49.26 58.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.559 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 -72.97 0.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.49 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.819 0.342 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -101.52 -177.08 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -98.06 -179.36 4.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.7 p-90 -167.92 -155.61 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 25.59 3.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.669 0.271 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -77.3 -31.64 50.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.511 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.441 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 90.2 t80 -47.96 116.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.274 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.46 95.77 4.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.058 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.03 -16.6 55.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.233 1.955 . . . . 0.0 112.236 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.36 -36.66 80.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.3 p -122.92 12.26 9.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.271 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.85 51.81 42.88 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.935 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.9 p -157.13 -177.86 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 77.1 m95 -110.14 156.32 20.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 74.9 mtp180 -60.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.555 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.9 t -170.33 -39.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t -45.81 -33.53 3.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.412 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.6 mm -125.63 155.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.819 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.92 132.96 32.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.3 p90 -97.38 179.1 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.82 -55.92 4.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.42 -88.99 0.94 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.467 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.848 0.356 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.36 122.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.0 111.087 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -100.44 176.29 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.445 ' CD1' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -170.09 -169.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.72 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -91.14 45.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.167 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -117.4 32.65 5.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.417 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -98.16 139.91 33.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.835 0.35 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.68 100.76 40.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.13 -32.51 6.76 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 0.0 112.189 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -54.2 -31.4 52.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.313 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 p -128.1 13.56 6.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 111.748 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.85 57.75 7.46 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.138 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.2 p -156.46 169.78 23.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 110.868 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 22' ' ' TYR . 80.2 m95 -97.76 -178.53 4.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -88.75 -79.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.2 m -166.54 -43.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 56.5 m -51.67 -30.38 21.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.081 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' CD1' ' A' ' 6' ' ' TRP . 47.6 mm -122.65 155.89 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.43 128.39 25.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.016 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 16' ' ' TRP . 33.5 p90 -105.24 164.21 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.289 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.73 66.18 1.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.552 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.12 -42.18 2.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.51 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 3' ' ' VAL . 9.2 p . . . . . 0 CA--C 1.52 -0.182 0 CA-C-O 121.28 0.562 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -170.21 128.05 0.85 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.015 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -100.21 165.83 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.6 p-90 -147.41 -161.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.512 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.9 m -95.43 46.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.97 29.13 7.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.595 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -91.49 120.71 32.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.607 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.08 89.78 1.4 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.072 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.86 -18.81 51.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 112.211 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -57.51 -42.03 82.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.0 110.457 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -118.53 13.89 13.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.385 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.8 47.32 18.94 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.006 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.5 p -155.86 155.05 32.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.8 m95 -86.96 155.6 20.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.785 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -105.43 -41.45 5.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.356 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.7 p -64.79 179.74 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -69.99 -12.3 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.153 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 21' ' ' ALA . 49.9 mm -60.43 157.73 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.48 123.8 7.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.7 p90 -95.07 162.96 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.34 73.88 0.52 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 -44.5 1.46 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.533 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.842 0.354 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -58.09 115.21 2.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -91.91 -24.33 19.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.463 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -162.41 -162.72 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.427 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 t -96.14 28.7 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.312 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -53.72 -26.98 34.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.687 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 76.4 t80 -54.98 121.02 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -103.28 105.92 48.8 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.403 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 11.8 Cg_exo -67.98 -36.91 16.38 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.51 2.14 . . . . 0.0 111.915 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -53.71 -26.56 23.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.274 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -134.54 15.81 3.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.66 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 41.46 51.99 4.5 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.41 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.4 p -154.42 153.12 31.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 41.5 m95 -88.49 -178.56 5.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -123.85 -62.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.084 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.419 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 53.2 m -59.37 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.158 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -70.41 -9.36 56.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.633 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.7 mp -60.3 155.88 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.736 0.303 . . . . 0.0 110.508 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -47.42 128.66 12.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.295 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 38.0 p90 -101.46 160.44 14.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.7 -55.28 4.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.91 100.59 0.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.556 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.808 0.337 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.42 126.72 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -99.94 166.09 11.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.822 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.06 -165.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -91.47 43.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.106 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.51 29.79 10.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.08 134.98 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -116.1 93.53 39.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.43 -21.55 53.4 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.33 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.5 -31.12 70.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.1 p -134.35 18.39 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 45.69 59.66 4.73 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.045 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -153.97 160.66 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.352 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.434 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 21.7 m95 -103.3 157.67 16.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -88.96 -73.01 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -52.5 -178.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -75.71 -5.21 44.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.498 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -57.32 159.87 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 110.8 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.47 124.53 4.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 111.386 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.5 p90 -96.81 164.27 12.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.961 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.9 -68.03 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.606 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.24 -44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.46 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.843 0.354 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -141.96 118.06 10.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.99 174.78 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.1 p-90 -169.92 -164.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.8 p -90.29 44.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -109.17 28.7 10.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.5 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -96.64 130.65 43.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.46 91.54 5.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.04 -22.42 73.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.384 2.056 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -62.07 -35.58 79.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.809 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.74 16.36 11.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.73 46.0 18.43 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.067 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -153.62 163.79 39.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.435 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 75.6 m95 -87.24 -178.7 6.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.74 -83.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.396 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -170.09 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.7 p -50.33 -31.8 15.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.146 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.2 mm -123.27 155.45 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -53.14 129.13 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 44.1 p90 -95.43 169.7 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.39 69.01 1.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.59 -65.06 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.433 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.501 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.669 0.271 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -90.56 147.23 23.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.165 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -100.02 152.91 19.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.443 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 6.2 p-90 -150.36 -154.22 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 m -91.97 35.31 0.98 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.646 0.26 . . . . 0.0 111.39 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.49 28.77 11.92 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.457 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -100.0 127.69 46.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 0.0 110.843 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.5 91.57 2.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 -19.19 62.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.428 2.085 . . . . 0.0 112.534 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -54.96 -33.44 62.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -134.83 15.06 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 111.479 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 64.95 3.65 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.009 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.7 p -156.66 163.37 39.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 80.7 m95 -104.26 157.6 17.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -58.65 -86.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.36 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -170.48 -41.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.299 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -50.98 -28.65 10.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.376 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -122.75 151.96 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.771 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.93 131.59 31.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 46.9 p90 -97.28 174.6 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.94 59.77 2.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.09 -66.22 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.369 -1.24 . . . . 0.0 112.482 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -90.87 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.746 0.308 . . . . 0.0 111.101 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -153.88 37.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -144.33 134.49 24.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.01 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.07 -178.55 3.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.472 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.4 p-90 -169.48 -152.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.318 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.9 m -90.95 26.57 2.07 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.22 35.2 4.59 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 73.4 t80 -97.13 123.16 40.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.728 0.299 . . . . 0.0 110.764 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.94 108.01 40.9 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.996 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -70.36 -34.29 12.85 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.419 2.079 . . . . 0.0 111.724 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -53.66 -29.84 40.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 p -127.27 14.05 7.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.674 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.63 27.81 3.27 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.2 p -133.3 164.58 26.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 111.092 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 95.8 m95 -81.57 -179.14 7.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.028 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -72.8 -82.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.359 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -170.25 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.776 0.322 . . . . 0.0 111.228 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 20' ' ' ILE . 30.0 p -52.0 -40.26 60.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.172 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.609 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.8 mp -101.95 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.627 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.02 105.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.989 0.423 . . . . 0.0 111.084 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -66.81 157.87 31.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.022 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.09 69.78 1.35 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.605 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.54 -84.79 0.99 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.513 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.391 -1.227 . . . . 0.0 112.547 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 2' ' ' VAL . 8.1 p -139.86 107.07 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 2' ' ' VAL . 27.7 m -158.29 37.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.092 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' O ' HD12 ' A' ' 20' ' ' ILE . 74.0 mtp180 -141.7 109.38 5.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.953 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -100.06 171.18 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.004 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.471 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.2 p-90 -170.11 -155.92 0.13 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.6 m -93.99 27.61 2.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.649 0.261 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -76.47 -27.94 60.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.563 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -49.49 118.65 2.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.867 0.365 . . . . 0.0 111.104 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 21.6 t70 -102.71 95.06 5.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.91 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 17.6 Cg_endo -59.56 -21.54 62.6 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.216 1.944 . . . . 0.0 112.073 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -67.88 -32.04 72.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.788 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.0 p -115.99 12.9 15.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.08 31.43 2.09 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.311 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -153.33 148.25 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 66.6 m95 -70.55 151.34 45.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.82 -43.54 6.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.226 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 65.0 p -65.25 177.59 1.06 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.072 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 53.7 m -70.07 -11.59 60.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.269 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 21' ' ' ALA . 38.4 mm -57.92 158.73 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.08 122.98 8.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.126 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -91.64 161.49 14.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.04 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.79 -55.93 5.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.76 -115.75 3.03 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.532 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.276 -1.291 . . . . 0.0 112.482 179.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.25 134.16 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.3 m -100.76 -176.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.031 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -74.33 147.03 42.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.021 0.439 . . . . 0.0 111.527 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' HG3' ' CH2' ' A' ' 16' ' ' TRP . 29.9 tt0 -100.12 160.57 14.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.414 ' N ' ' HG2' ' A' ' 5' ' ' GLN . 2.0 p-90 -167.47 -161.04 0.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.65 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -56.55 -18.54 12.08 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.37 -28.41 2.2 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.955 -0.64 . . . . 0.0 113.073 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -80.36 117.39 21.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -108.08 92.48 9.41 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.062 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 15.3 Cg_endo -58.35 -19.94 45.64 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.319 2.013 . . . . 0.0 112.128 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -69.97 -43.51 71.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.8 p -102.4 13.45 34.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.14 28.0 4.0 Favored Glycine 0 CA--C 1.517 0.157 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.023 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.4 p -148.23 154.35 39.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.942 0.401 . . . . 0.0 111.097 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.467 ' CG ' ' HA ' ' A' ' 22' ' ' TYR . 16.6 m95 -83.17 -176.86 6.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -87.96 -79.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.7 t -170.28 -41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 111.237 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.7 t -50.48 -37.95 41.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.314 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' CG2' ' A' ' 3' ' ' VAL . 41.5 mm -119.15 157.88 20.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.26 133.4 19.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.467 ' HA ' ' CG ' ' A' ' 16' ' ' TRP . 43.4 p90 -105.06 163.2 12.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.09 6.12 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.603 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 124.61 -93.81 0.46 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' ' CZ2' ' A' ' 16' ' ' TRP . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.465 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 2' ' ' VAL . 7.8 p -138.05 105.11 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.944 0.402 . . . . 0.0 111.078 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 2' ' ' VAL . 23.9 m -157.31 32.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.249 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -170.36 114.91 0.48 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.043 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -99.97 161.89 13.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.442 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 7.2 p-90 -152.73 -152.14 0.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -94.48 33.92 1.36 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.669 0.271 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -90.58 -30.23 12.27 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.668 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -54.54 116.02 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.873 0.368 . . . . 0.0 110.929 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.93 107.18 48.43 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.988 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.56 -36.15 20.59 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.463 2.108 . . . . 0.0 111.58 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -54.0 -30.41 47.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.246 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.8 p -119.97 9.9 11.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.786 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.06 29.62 1.58 Allowed Glycine 0 CA--C 1.519 0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.247 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.3 p -144.47 152.03 40.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.908 0.385 . . . . 0.0 111.266 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.483 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 30.1 m95 -81.24 174.73 11.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.815 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -131.54 -43.35 1.02 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 111.425 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 t -65.61 -171.11 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.031 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.3 m -69.54 -12.59 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.231 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 16' ' ' TRP . 43.8 mm -61.88 152.41 6.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.736 0.303 . . . . 0.0 110.777 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.26 122.85 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.8 p90 -91.46 162.64 14.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.213 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 -29.25 12.06 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.93 113.43 0.44 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.317 -1.268 . . . . 0.0 112.54 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.33 127.75 44.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.834 0.349 . . . . 0.0 111.085 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 20' ' ' ILE . 35.0 m -149.91 -177.57 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.034 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -85.16 151.98 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.85 177.69 5.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.465 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.6 p-90 -170.02 -158.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.479 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.8 m -94.77 39.97 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.7 0.286 . . . . 0.0 111.2 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -94.75 -26.45 13.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.659 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HB2' ' CZ2' ' A' ' 16' ' ' TRP . 89.2 t80 -49.56 119.44 3.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 111.11 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -101.46 94.51 4.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.8 -15.58 49.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.331 2.021 . . . . 0.0 112.287 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -62.67 -40.81 98.24 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.7 p -120.64 13.49 11.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.498 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 48.33 59.35 6.51 Favored Glycine 0 CA--C 1.517 0.212 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.204 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -157.34 175.43 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.474 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.0 m95 -113.76 116.09 28.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.87 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -68.92 -45.77 69.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.591 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 82.6 p -66.37 169.7 7.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.151 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.4 m -63.64 -17.21 62.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG23 HG23 ' A' ' 3' ' ' VAL . 38.4 mm -50.85 155.09 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.936 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.0 125.74 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.884 0.373 . . . . 0.0 111.242 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.474 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 32.3 p90 -100.8 161.38 13.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.23 59.27 11.0 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.96 -100.81 0.28 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.377 -1.235 . . . . 0.0 112.49 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.56 148.34 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.437 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.1 m -150.33 -177.02 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -65.09 137.39 57.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.953 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -100.19 169.78 8.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -170.02 -155.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.444 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.9 m -75.13 0.61 15.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -49.97 -26.38 8.55 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.853 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.433 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 85.2 t80 -76.42 116.6 17.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.78 0.324 . . . . 0.0 110.919 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 m-20 -112.59 100.81 51.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.988 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 19.7 Cg_endo -59.76 -24.03 74.17 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.291 1.994 . . . . 0.0 112.135 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -59.53 -31.05 69.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.727 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -122.31 12.28 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.44 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.5 28.13 4.69 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.034 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.3 p -150.12 143.08 24.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.466 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 69.4 m95 -63.69 177.27 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HA ' ' HD2' ' A' ' 17' ' ' ARG . 24.1 mmm180 -81.27 -83.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.414 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.2 p -170.11 -38.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.338 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.2 p -47.22 -41.21 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.77 0.319 . . . . 0.0 111.249 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 21' ' ' ALA . 45.1 mm -118.42 156.33 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.739 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -50.81 130.6 25.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.466 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 47.5 p90 -94.1 -178.69 4.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.15 41.74 59.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.593 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.85 102.33 2.2 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.415 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.358 -1.246 . . . . 0.0 112.531 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -60.64 130.57 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.4 m -147.66 178.73 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -82.01 127.29 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.16 158.38 15.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.98 0.419 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -170.08 -156.37 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.29 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -63.63 -11.69 27.32 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.04 -27.45 3.53 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.194 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -80.53 117.45 21.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.785 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 7.5 m-20 -115.22 102.67 54.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.087 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.7 Cg_endo -60.68 -17.21 48.16 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.284 1.989 . . . . 0.0 112.297 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 12' ' ' ARG . 4.7 mmp_? -57.03 -31.95 65.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.911 0.386 . . . . 0.0 110.576 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.4 p -131.97 13.17 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.42 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.9 35.94 25.78 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.989 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -147.94 139.94 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.204 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.461 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 54.1 m95 -60.9 -175.5 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.604 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -96.64 -83.66 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.311 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -160.05 -43.17 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.6 m -47.97 -37.46 14.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 0.0 111.155 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 21' ' ' ALA . 42.5 mm -120.05 155.65 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.715 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.69 129.24 19.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.1 p90 -105.87 164.8 11.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.067 0.46 . . . . 0.0 111.088 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.77 53.52 2.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.54 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.98 -82.03 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.506 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.502 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.366 -0.294 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 3' ' ' VAL . 9.2 p -142.38 126.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 111.068 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 2' ' ' VAL . 23.8 m -156.92 35.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -170.23 108.23 0.35 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.227 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 10.2 tt0 -100.2 143.77 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 7' ' ' SER . 7.7 p-90 -163.53 -153.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.438 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.415 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 49.6 m -64.55 -7.09 9.01 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.26 -28.74 1.47 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.065 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 91.6 t80 -78.35 120.6 23.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.903 0.382 . . . . 0.0 110.661 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 10.3 m-20 -112.12 98.2 41.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.061 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 10' ' ' ASP . 18.0 Cg_endo -61.23 -23.09 76.43 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.248 1.966 . . . . 0.0 112.068 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -60.35 -38.96 85.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.757 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -115.33 13.87 16.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.484 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.21 37.9 8.33 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.137 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.7 p -151.49 156.08 39.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.994 0.426 . . . . 0.0 111.197 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 9' ' ' TYR . 56.0 m95 -84.48 159.34 20.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.879 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -63.68 -78.34 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.401 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 80.1 p -170.04 -41.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.157 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -50.95 -30.4 14.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 57.3 mt -111.94 147.82 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.664 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.66 95.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.664 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 23.3 p90 -61.75 164.17 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.327 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.67 38.41 7.57 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 139.84 -88.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.561 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.476 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.37 141.1 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.995 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -148.87 38.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -135.64 138.31 42.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.226 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.08 168.62 9.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.903 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.452 ' NE1' HD13 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -170.07 -166.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.611 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -90.84 48.45 1.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.076 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -110.45 -28.39 4.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.641 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 88.2 t80 -57.48 136.86 56.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.051 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -109.19 102.35 48.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.779 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.78 -37.57 44.71 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.333 2.022 . . . . 0.0 111.5 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -54.0 -28.88 40.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.265 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.5 p -117.82 7.92 12.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.94 48.56 6.28 Favored Glycine 0 CA--C 1.518 0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.421 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.7 p -156.31 151.8 26.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.947 0.403 . . . . 0.0 111.117 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 63.2 m95 -86.9 164.33 16.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.1 mmp_? -62.66 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.7 t -170.19 -44.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.824 0.345 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.6 t -55.97 -37.2 68.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.658 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -103.76 148.91 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.788 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.42 131.65 48.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.6 p90 -95.03 161.88 13.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.007 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.4 48.72 1.8 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.41 33.38 39.47 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.527 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.494 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.8 127.14 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.878 0.37 . . . . 0.0 111.0 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.2 m -154.51 37.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.099 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -133.94 131.78 39.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.815 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.37 174.95 6.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -170.01 -164.71 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.465 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -89.91 44.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.857 0.36 . . . . 0.0 111.225 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.92 32.56 5.92 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.458 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -99.52 123.62 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -101.96 91.74 2.6 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.054 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.04 -22.04 73.5 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.273 1.982 . . . . 0.0 112.12 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -62.32 -36.08 81.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.742 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.32 16.76 11.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.509 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.77 46.67 18.87 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.985 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 50.1 p -154.66 157.36 38.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.951 0.405 . . . . 0.0 111.122 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 90.0 m95 -78.46 -177.59 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.771 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -77.98 -83.15 0.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.254 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 71.1 m -169.22 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.1 m -50.38 -36.62 33.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.368 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.6 mm -114.12 156.77 15.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.75 123.39 11.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.097 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 42.2 p90 -85.91 162.57 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.134 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.75 72.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.547 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.53 -46.98 1.09 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.591 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.45 -1.194 . . . . 0.0 112.567 -179.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 3' ' ' VAL . 14.6 p -97.92 159.0 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 110.968 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.469 ' N ' HG22 ' A' ' 2' ' ' VAL . 30.0 m -155.3 42.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.79 0.328 . . . . 0.0 111.526 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -153.02 104.24 2.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.96 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -100.5 162.59 12.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 6.1 p-90 -160.57 -153.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.146 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -95.21 38.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -93.26 -29.38 10.32 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.793 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -53.6 113.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 0.0 110.92 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -98.58 109.0 51.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.27 -38.85 25.16 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.371 2.047 . . . . 0.0 111.842 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -51.49 -47.37 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.074 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 p -101.91 9.47 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.862 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 42.97 30.08 0.96 Allowed Glycine 0 CA--C 1.519 0.307 0 CA-C-N 116.068 -0.514 . . . . 0.0 113.372 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.5 p -145.48 152.56 39.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.916 0.388 . . . . 0.0 111.292 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.458 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 27.9 m95 -76.81 160.4 29.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -116.47 -31.63 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 66.7 p -78.66 -175.58 4.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.3 t -67.56 -17.36 64.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 HG23 HG21 ' A' ' 2' ' ' VAL . 24.7 mm -56.89 149.43 3.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.766 0.317 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 120.19 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 111.179 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 40.1 p90 -83.62 165.82 18.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.139 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.13 27.53 62.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.491 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.97 151.36 5.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.408 -1.218 . . . . 0.0 112.494 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -140.14 128.84 26.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.4 m -115.18 -174.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.402 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -139.32 171.68 13.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.822 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -92.2 171.13 9.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -169.96 -165.93 0.52 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.577 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -90.04 46.42 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -114.93 29.82 7.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.593 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -95.69 126.26 40.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.749 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -106.92 103.64 48.32 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -64.67 -38.67 30.39 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.372 2.048 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -53.15 -29.41 31.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.164 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.5 p -119.97 11.17 11.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.706 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 44.77 29.12 1.88 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.171 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 77.3 p -147.54 155.57 41.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 111.214 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 22' ' ' TYR . 84.9 m95 -69.22 -176.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.818 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -80.57 -77.28 0.2 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.215 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -170.12 -40.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.2 p -51.15 -31.71 20.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.094 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -117.33 157.21 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -54.02 112.15 0.9 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.232 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 16' ' ' TRP . 46.9 p90 -65.46 152.24 44.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.37 53.38 46.04 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.43 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.8 113.21 1.26 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.447 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.431 -1.205 . . . . 0.0 112.537 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.3 t -84.23 147.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.338 . . . . 0.0 111.031 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' CG2' HG23 ' A' ' 20' ' ' ILE . 35.4 m -148.4 -177.47 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.02 129.07 38.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.278 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.22 176.46 5.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 4.7 p-90 -170.01 -154.64 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -93.6 23.46 4.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.671 0.272 . . . . 0.0 111.43 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -69.71 -33.8 71.73 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.488 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 38.8 t80 -58.19 125.38 22.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.432 . . . . 0.0 111.09 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.7 95.0 39.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.502 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -64.02 -13.55 38.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.638 2.226 . . . . 0.0 112.952 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -60.74 -33.89 73.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.952 0.406 . . . . 0.0 110.606 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 t -138.42 17.87 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 49.79 67.99 1.58 Allowed Glycine 0 CA--C 1.518 0.256 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.971 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 p -154.24 169.14 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.242 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.487 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 16.7 m95 -121.46 154.23 36.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.818 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.58 -66.34 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.349 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.6 t -58.57 -175.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.173 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.2 m -81.32 -0.64 41.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.426 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.3 mm -61.55 160.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.511 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.7 123.3 4.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.796 0.332 . . . . 0.0 111.159 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.487 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 27.5 p90 -103.94 172.91 6.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.281 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 66.2 49.26 58.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.559 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.74 -72.97 0.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.49 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.4 t -83.64 126.91 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.8 m -146.39 -178.71 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.166 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -101.52 -177.08 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -98.06 -179.36 4.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.07 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 3.7 p-90 -167.92 -155.61 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.269 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -93.33 25.59 3.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.669 0.271 . . . . 0.0 111.482 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -77.3 -31.64 50.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.511 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.441 ' HB2' ' CH2' ' A' ' 16' ' ' TRP . 90.2 t80 -47.96 116.05 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.977 0.418 . . . . 0.0 111.274 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.46 95.77 4.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.058 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.03 -16.6 55.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.233 1.955 . . . . 0.0 112.236 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -61.36 -36.66 80.82 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.619 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.3 p -122.92 12.26 9.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.271 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.85 51.81 42.88 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.935 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.9 p -157.13 -177.86 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 9' ' ' TYR . 77.1 m95 -110.14 156.32 20.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.513 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 8' ' ' GLY . 74.9 mtp180 -60.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.555 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.9 t -170.33 -39.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.73 0.3 . . . . 0.0 111.353 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.0 t -45.81 -33.53 3.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.412 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 21' ' ' ALA . 39.6 mm -125.63 155.8 35.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.819 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.92 132.96 32.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.294 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 48.3 p90 -97.38 179.1 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.82 -55.92 4.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -122.42 -88.99 0.94 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.467 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.136 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 3' ' ' VAL . 11.0 p -67.57 158.13 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.685 0.278 . . . . 0.0 110.85 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' N ' HG22 ' A' ' 2' ' ' VAL . 31.1 m -132.96 39.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.848 0.356 . . . . 0.0 111.616 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -170.36 122.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.007 0.432 . . . . 0.0 111.087 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -100.44 176.29 5.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.801 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.445 ' CD1' HG13 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -170.09 -169.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.72 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -91.14 45.63 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.167 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -117.4 32.65 5.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.417 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -98.16 139.91 33.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.835 0.35 . . . . 0.0 110.818 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.68 100.76 40.46 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.13 -32.51 6.76 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.702 2.268 . . . . 0.0 112.189 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -54.2 -31.4 52.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.313 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 p -128.1 13.56 6.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.87 0.367 . . . . 0.0 111.748 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 47.85 57.75 7.46 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.138 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.2 p -156.46 169.78 23.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 110.868 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 22' ' ' TYR . 80.2 m95 -97.76 -178.53 4.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.821 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -88.75 -79.85 0.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.2 m -166.54 -43.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 0.0 111.117 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.415 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 56.5 m -51.67 -30.38 21.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.081 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' CD1' ' A' ' 6' ' ' TRP . 47.6 mm -122.65 155.89 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.439 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -52.43 128.39 25.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.016 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 16' ' ' TRP . 33.5 p90 -105.24 164.21 12.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.289 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.73 66.18 1.33 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.552 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.12 -42.18 2.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.51 -179.913 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.85 137.66 22.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 110.979 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 3' ' ' VAL . 9.2 p -170.09 33.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.28 0.562 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -170.21 128.05 0.85 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.015 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -100.21 165.83 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.97 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.6 p-90 -147.41 -161.84 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.512 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.9 m -95.43 46.61 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.199 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -113.97 29.13 7.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.595 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -91.49 120.71 32.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.829 0.347 . . . . 0.0 110.607 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.08 89.78 1.4 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.072 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.86 -18.81 51.37 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.319 2.013 . . . . 0.0 112.211 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -57.51 -42.03 82.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.977 0.418 . . . . 0.0 110.457 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 p -118.53 13.89 13.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.385 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.8 47.32 18.94 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.006 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.5 p -155.86 155.05 32.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 111.261 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.432 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 66.8 m95 -86.96 155.6 20.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.785 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -105.43 -41.45 5.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.356 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 33.7 p -64.79 179.74 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.096 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.9 t -69.99 -12.3 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.153 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 21' ' ' ALA . 49.9 mm -60.43 157.73 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.756 0.312 . . . . 0.0 110.709 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -48.48 123.8 7.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.067 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 34.7 p90 -95.07 162.96 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 64.34 73.88 0.52 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.476 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 -44.5 1.46 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.526 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.533 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.85 129.94 36.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 111.02 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -152.57 162.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -58.09 115.21 2.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -91.91 -24.33 19.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.463 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -162.41 -162.72 0.84 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.427 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.4 t -96.14 28.7 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.312 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -53.72 -26.98 34.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.687 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' HB2' ' CE2' ' A' ' 16' ' ' TRP . 76.4 t80 -54.98 121.02 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -103.28 105.92 48.8 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.403 ' HD2' ' CZ ' ' A' ' 12' ' ' ARG . 11.8 Cg_exo -67.98 -36.91 16.38 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.51 2.14 . . . . 0.0 111.915 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' CZ ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -53.71 -26.56 23.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.274 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -134.54 15.81 3.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.66 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 41.46 51.99 4.5 Favored Glycine 0 CA--C 1.519 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.41 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.4 p -154.42 153.12 31.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.378 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.465 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 41.5 m95 -88.49 -178.56 5.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -123.85 -62.29 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.084 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.419 ' OG ' ' CZ2' ' A' ' 6' ' ' TRP . 53.2 m -59.37 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.158 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.5 p -70.41 -9.36 56.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.633 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.7 mp -60.3 155.88 3.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.736 0.303 . . . . 0.0 110.508 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 20' ' ' ILE . . . -47.42 128.66 12.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.295 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 38.0 p90 -101.46 160.44 14.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.16 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.7 -55.28 4.66 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.468 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.91 100.59 0.28 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.556 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.476 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.546 -0.222 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.01 165.75 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.826 0.346 . . . . 0.0 111.177 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.5 m -149.71 -175.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.968 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -87.42 126.72 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -99.94 166.09 11.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.822 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -170.06 -165.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.615 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.1 p -91.47 43.08 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.106 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -97.51 29.79 10.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.548 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.08 134.98 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -116.1 93.53 39.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.87 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.43 -21.55 53.4 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.398 2.066 . . . . 0.0 112.33 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.5 -31.12 70.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.1 p -134.35 18.39 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 45.69 59.66 4.73 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.045 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.2 p -153.97 160.66 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.352 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.434 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 21.7 m95 -103.3 157.67 16.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -88.96 -73.01 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.6 t -52.5 -178.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.256 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 79.5 p -75.71 -5.21 44.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.498 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' ALA . 43.3 mm -57.32 159.87 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 110.8 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -45.47 124.53 4.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.873 0.368 . . . . 0.0 111.386 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 35.5 p90 -96.81 164.27 12.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.961 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.9 -68.03 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.606 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.24 -44.85 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.38 -1.233 . . . . 0.0 112.46 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.5 p -100.67 129.01 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 111.095 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 m -153.87 37.17 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.989 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -141.96 118.06 10.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -99.99 174.78 6.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.439 ' CD1' HG13 ' A' ' 20' ' ' ILE . 1.1 p-90 -169.92 -164.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.533 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.8 p -90.29 44.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.438 ' HA3' ' CE2' ' A' ' 6' ' ' TRP . . . -109.17 28.7 10.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.5 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -96.64 130.65 43.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.46 91.54 5.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.04 -22.42 73.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.384 2.056 . . . . 0.0 112.129 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -62.07 -35.58 79.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.809 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 p -121.74 16.36 11.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 46.73 46.0 18.43 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.067 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.1 p -153.62 163.79 39.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 111.18 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.435 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 75.6 m95 -87.24 -178.7 6.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.883 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 17' ' ' ARG . 6.0 mmp_? -82.74 -83.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.396 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.1 t -170.09 -40.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.726 0.298 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.7 p -50.33 -31.8 15.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.146 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' CD1' ' A' ' 6' ' ' TRP . 43.2 mm -123.27 155.45 29.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -53.14 129.13 30.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 111.122 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 44.1 p90 -95.43 169.7 9.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.39 69.01 1.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.59 -65.06 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.433 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.501 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.3 t -105.2 139.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.811 0.339 . . . . 0.0 111.058 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -146.95 -175.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -90.56 147.23 23.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 111.165 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -100.02 152.91 19.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.96 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.443 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 6.2 p-90 -150.36 -154.22 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 m -91.97 35.31 0.98 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.646 0.26 . . . . 0.0 111.39 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.49 28.77 11.92 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.457 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -100.0 127.69 46.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 0.0 110.843 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -102.5 91.57 2.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 -19.19 62.21 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.428 2.085 . . . . 0.0 112.534 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -54.96 -33.44 62.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.986 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -134.83 15.06 3.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.991 0.424 . . . . 0.0 111.479 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.63 64.95 3.65 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.009 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.7 p -156.66 163.37 39.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 22' ' ' TYR . 80.7 m95 -104.26 157.6 17.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.702 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -58.65 -86.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.36 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -170.48 -41.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.729 0.299 . . . . 0.0 111.221 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.0 t -50.98 -28.65 10.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.376 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 20' ' ' ILE . 4.1 mp -122.75 151.96 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.771 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.93 131.59 31.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.132 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 16' ' ' TRP . 46.9 p90 -97.28 174.6 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.056 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.94 59.77 2.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.436 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.09 -66.22 0.24 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.481 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.369 -1.24 . . . . 0.0 112.482 179.966 . . . . . . . . 0 0 . 1 stop_ save_